


































TURUN YLIOPISTON JULKAISUJA –  ANNALES UNIVERSITATIS TURKUENSIS
SARJA - SER. AI OSA  - TOM. 599  |  ASTRONOMICA - CHEMICA - PHYSICA - MATHEMATICA  |  TURKU 2019
ELECTROENCAPSULATION 
AND ELECTROSPRAYING OF 
PHARMACEUTICAL MATERIALS 
IN PREPARATION FOR ORAL 
DRUG DELIVERY APPLICATIONS
Jorma Roine
31004982_Turun_yliopisto_Vaitoskirja_Jorma_Roine_Luonn_tiet_ja_tekn_tdk_kansi_19_01_22.indd   1 22.1.2019   8.19.37
TURUN YLIOPISTON JULKAISUJA –  ANNALES UNIVERSITATIS TURKUENSIS
SARJA - SER. AI OSA  - TOM. 599  |  ASTRONOMICA - CHEMICA - PHYSICA - MATHEMATICA  |  TURKU 2019
Jorma Roine
ELECTROENCAPSULATION  
AND ELECTROSPRAYING OF 
PHARMACEUTICAL MATERIALS 
IN PREPARATION FOR ORAL 
DRUG DELIVERY APPLICATIONS













Laboratory of Industrial Physics
Department of Physics and Astronomy












Pprime Institute: Mechanical, Materials and Energy Engineering and Research
University of Poitiers
France
The originality of this thesis has been checked in accordance with the 






Grano Oy - Turku, Finland 2019
Leena Peltonen
Adjunct Professor






In February 2005, during my M.Sc. studies at the University of Turku, I was
asked out of the blue by Dr. Matti Murtomaa to work in the Laboratory of
Industrial Physics as a part-time research assistant. I was thrilled and honored
to get introduced to the inspiring crew and environment of our laboratory.
More of my dreams would soon after continue to be fulfilled. I spent the
academic year 2005–2006 in Japan to study the language, after to return to
Turku to finish my Master’s degree in physics. Little did I know that on the day
of my return in August 2006, I would have the pleasure to meet the love of my
life in the laboratory: Dr. Maija Nyström, who at the time was a fellow
undergraduate student. By June 2007, we were officially dating, and I had
joined her band. We would both go on working in the laboratory, to later
dissertate in the interdisciplinary fields of electrostatics and pharmaceutical
physics. On September 1st, 2008, I finally embarked on my Ph.D. journey.
Let us briefly dwell on the significance of science. Humanity has always
found a way to adapt or turn its course in times of crisis, to live another day.
That being said, the true will to change our ways often only emerges when but a
few choices remain. Currently, we are faced with unprecedented global
challenges – overpopulation, extinction of wildlife, and climate change, which
threaten loss of the Earth’s biodiversity, and an ecological collapse. It is
paramount for the future of our descendants and our planet that we deal with
these problems resolutely today. I am hopeful that this can be realized. Science
provides us with peaceful solutions to help us live our lives, and we have been
invested with the power to influence our fate by making rational decisions. We
can choose to partake in the effort by contributing to the advancement of
science, whether or not we get to witness the outcome.
So if you ask me, scientific research and access to established knowledge
hold more value now than ever before, and should not to be taken for granted.
In the recent times, we have had the opportunity to witness plenty of incidents
where the general public has been alienated from the meticulously established
scientific views, or blatantly disconnected from scientific efforts to improve
human lives – often for short-sighted personal gain of few. Of course, this is not
a new phenomenon. At times throughout the known history, irresponsible
misrepresentation or even demonization of science due to selfish reasons has
dangerously threatened to undermine scientific progress by fueling public
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tension over it. Human as such acts may be, regrettably they often are far from
humane. Our advanced society exists owing to our natural eagerness and
unrelenting efforts to explore and understand the world around us. Let us
continue to engage in critical thinking, to question, and to follow our innate
curiosity. Our collective discoveries – the fruits of science – belong to everyone.
In the form of this Ph.D. thesis, I am happy to contribute to the ocean of
humanity’s knowledge, if only a small vial – with a droplet of something new. I
sincerely hope my present and future work may serve for the incremental
betterment of humankind. I would like to take this opportunity to express my
gratitude to the people who have made the completion of this work possible.
I humbly thank my opponent, Prof. Lucian Dascalescu. Prof. Wamadeva
Balachandran and Dr. Leena Peltonen are acknowledged for reviewing the
thesis.
Dr. Matti Murtomaa and Prof. Jarno Salonen, you had faith in me, shared
your expertise, and provided me the freedom to pursue research in an excellent
environment – thank you. Matti, your whole-hearted pioneering spirit and
enthusiasm for electrostatics never fail to inspire those around you. Jarno, your
dedication in porous silicon research is likewise exceptional. I appreciate your
efforts as laboratory head to gather funding and to offer part-time work
projects in difficult times to support this Ph.D. project, as well as others.
Prof. Vesa-Pekka Lehto, as the head of the laboratory when I started out, you
believed in me, and I’m grateful. Thank you for sharing your insights, and for
providing funding to the project during the crucial first months.
The Graduate School of Materials Research (GSMR) is acknowledged for
three-year funding of the Ph.D. project throughout 2009-2011. The Finnish
Cultural Foundation, Varsinais-Suomi Regional Fund, funded the work for one
year. A minor grant received from Turun Yliopistosäätiö is also acknowledged.
I sincerely thank all of my past and present colleagues, in particular the
graduate students, who were always willing to help one another, and essential
in defining the pleasant tone and solidary mood of our laboratory. Special
thanks to Dr. Maija Nyström for the shared laughs, our fruitful discussions, and
the co-authoring which was crucial for the completion of this thesis; Dr. Martti
Kaasalainen, for the friendly support, long discussions, and collaboration;
Ermei Mäkilä, for selflessly sharing your time on countless occasions; Outi
Alanen and Janne Peltonen, for your uplifting resonance. For the work on the
electroencapsulation apparatus, thank you to Mika Aarnio, and our workshop
staff including Pasi Saarenmaa. The contributions from co-writers outside the
v
department are heartily acknowledged: Prof. Hélder Santos and his group;
Prof. R. Mohan Sankaran; Dr. Markus Peurla; and Dr. Markko Myllys.
To all of my friends – I have been most grateful for your company during
this work, you have given me your acceptance, and strength. I will never forget
you. Special thanks to all my bandmates in Korpikuusen Kyynel during these
years. The true veterans and staples in the band – Maija, Ville, and Antti – you
deserve my utmost megathanks. Our bond is strong and special... just like
heavy metal! Whenever we tell our stories in melody, or blow off our steam in
harmony, I am bound by the laws of physics no more.
Thanks to my relatives, and my wonderful in-laws for the welcoming
atmosphere and cheers. I feel at home with you.
To my family, thank you all for your support. Jyrki, as my big brother you
have always had my back, and you have always listened. I am glad to have
followed you to pursue my university studies in Turku. My sister Jaana, you
were the one to introduce me to mathematics early on. Maija & Lauri, I am
proud to call you my parents. I appreciate your love, your teachings, and the
freedom to choose my own ambitions. I am thankful that we were able to raise
a toast together to celebrate the completion of this Ph.D. thesis. My grandfather
Arvi Sevola has also been a great influence for me, and we often discussed my
early studies.
Finally, to my beloved fiancée Maija: For me, your beautiful smile is a
fundamental force. Your love, warm encouragement, and radiant positivity
have elevated me over the obstacles I have faced. From the bottom of my heart,
I thank you for patiently standing at my side throughout this undertaking –
sharing the countless moments of joy and hardship I’ve had, all the good times
and the bad. I cherish every drop of the invaluable wisdom and morale, and the
priceless humor you have sprinkled on me. For the pure joy of each day spent
with you, I am in bliss. For the privilege of having worked alongside you, I am
deeply honored. Yhes myö taistellaa.
Turku, December 2018
Jorma Roine
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Abstract
In bi-polar parallel nozzle electroencapsulation, two oppositely charged droplet
jets are produced by electrospraying (electrostatic atomization), a method of
extracting micro- or nanodroplets from a body of liquid using electrical forces.
The two species of droplets are attracted to each other due to Coulombic forces.
Upon contact, droplets of similar size can merge into a single-phase, or form a
core-shell capsule structure, depending on the mutual miscibility of the liquids.
In this work, an electroencapsulation setup was designed and experimented
for the single-step production of two types of drug carrier particles of 10–50 µm
in size: wrinkled, solid Eudragit L 100 enteric polymer micromatrix particles;
and spherical microcapsules consisting of a solid Eudragit E 100 polymer shell
and a liquid glycerol core. The carrier particle payload consisted of a model
drug (griseofulvin); or griseofulvin loaded, mesoporous silicon (PSi) nano- and
microparticles, which themselves are functional drug carriers. The goal was to
obtain the carrier particle payloads as either stable drug dispersions in a
disordered solid state, or non-agglomerated PSi nanoparticle dispersions, to
enhance the drug dissolution properties at release. The carrier formulations
would effectively render the payload in the form of an inert micropowder for
purposes of handling and dosing. In oral administration, the formulations were
to shield the payload from intestinal metabolism, and to restrain its release
until arrival to target pH-conditions.
The carrier particles were characterized to evaluate these properties. The
micromatrix particles were proven stable and gastro-resistant in vitro.
Griseofulvin dissolution and absorption properties improved significantly, the
latter especially for the drug loaded PSi payloads. Finally, the efficiency of the
asymmetric core-shell microcapsule production was optimized using Taguchi
techniques. In conclusion, electroencapsulation was found to be a potentially
feasible method to improve the oral bioavailability of poorly soluble drugs.
Furthermore, partially crystalline piroxicam microparticles were produced
by electrospraying, and characterized. The crystalline phase was shown to
consist of a previously unknown, stable polymorphic form of piroxicam. The
result suggests the method could provide a unique way to produce novel drug
polymorphs. Thus, it is possible that the dissolution properties of certain drug
materials could be improved sufficiently to facilitate oral administration,
without the necessity to use more complex formulations.
vii
Tiivistelmä
Vastakkaismerkkisin rinnakkaissuuttimin tehtävässä sähkökapseloinnissa
tuotetaan kaksi vastakkaisesti varautunutta pisarasuihkua sähköstaattisen
atomisaation avulla. Erimerkkisesti varautuneiden nesteiden pisarat vetävät
toisiaan puoleensa. Saman kokoluokan pisarat voivat siten yhdistyessään
sekoittua yhtenäiseksi faasiksi tai muodostaa kapselirakenteen kerrostumalla
toistensa päälle, riippuen nesteiden keskinäisestä sekoittuvuudesta.
Tässä väitöstutkimuksessa suunniteltiin sähkökapselointilaitteisto, jonka
avulla tuotettiin kahdenlaisia suun kautta annettavaksi tarkoitettuja
lääkekuljetinpartikkeleita 10–50 µm:n kokoluokassa: poimuisia Eudragit L 100
-polymeerimikromatriisipartikkeleita sekä pallomaisia mikrokapseleita, joissa
oli kiinteä Eudragit E 100 -polymeerikuori ja nestemäinen glyseroliydin.
Kuljetinpartikkelien hyötykuormana käytettiin griseofulviinia joko sellaisenaan
tai ladattuna mesohuokoisesta piistä (PSi) koostuvien mikro- tai
nanopartikkelien huokosiin. Yksivaiheisen tuotantoprosessin tarkoitus oli
parantaa lääkeaineen liukenevuutta sen vapautuessa kuljetinpartikkeleista. Siksi
puhtaan lääkeaineen haluttiin kapseloituvan kuljettimiin järjestäytymättömänä,
kiinteänä dispersiona. Lääkeainein ladatut PSi-partikkelit dispergoitiin
kuljetinväliaineeseen agglomeroitumattomina. Kuljetinpartikkelien tehtävinä
oli vakauttaa hyötykuorma ja helpottaa sen käsittelemistä, suojata kuormaa
ruoansulatuksen metabolialta ja lopuksi vapauttaa se tietyissä pH-olosuhteissa.
Lääkekuljetinpartikkelien ominaisuuksia arvioitiin eri menetelmin.
Mikromatriisipartikkelit osoittautuivat stabiileiksi ja gastroresistenteiksi in
vitro. Vapautuneen griseofulviinin liukenevuus parani merkittävästi, kuten
myös sen imeytyminen – erityisesti PSi:hin ladattaessa. Epäsymmetrisen
mikrokapselituotantoprosessin tehokkuus optimoitiin Taguchi-menetelmin.
Sähkökapselointi todettiin lupaavaksi menetelmäksi suun kautta annettavien
niukkaliukoisten lääkeaineiden biologisen hyötyosuuden parantamiseksi.
Tutkimuksessa tuotettiin lisäksi sähköstaattisen atomisaation avulla osittain
kiteisiä piroksikaamimikropartikkeleita, joiden kiteisen faasin todettiin
koostuvan entuudestaan tuntemattomasta stabiilista polymorfista. Löydös
viittaa mahdollisuuteen, että uusia kiderakenteita voitaisiin tuottaa menetelmän
avulla muistakin lääkeaineista. Näin tälläkin menetelmällä olisi kenties
mahdollista parantaa joidenkin lääkeaineiden liukenevuutta riittävästi niiden
antamiseksi suun kautta, turvautumatta monimutkaisempaan formulointiin.
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Constants, Quantities and Abbreviations
e = 1.6021773 × 10-19 C  Elementary charge
g = 9.80665 m/s2  Acceleration due to gravity (standard)
G = 6.67259 × 10-11 Nm2/kg2 Gravitational constant
ε0 = 8.85419 × 10-12 F/m  Vacuum permittivity
a  Distance between guard and extractor electrodes
c  Thickness of extractor electrode
d  Droplet diameter (size)
�̅  Volume mean droplet diameter
d0  Characteristic jet diameter
di Nozzle inner diameter
dj Jet diameter
dmed Volume median droplet diameter
do Nozzle outer diameter
h  Perpendicular distance between extractor electrode and nozzle tip
l  Droplet trajectory length
m  Mass
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1. Introduction
Drug materials are usually administered via the oral route, if possible. The
method is relatively comfortable for the patient, cost effective, and provides
good dosing control. However, oral drug administration is not always feasible.
It has been estimated that most new promising drug candidates suffer from
poor physicochemical or pharmacokinetic properties such as low solubility,
slow dissolution rate in the intestinal lumen, poor permeation of the
gastrointestinal (GI) tract wall, and high first-pass metabolism [1–4]. As a
result, an adequate bioavailability of the drug may not be obtainable when the
drug is administered orally.
Strategies exist to address drug oral bioavailability issues, and the relevant
drug properties can be enhanced. For instance, the drug dissolution can be
improved by increasing the specific surface area of the drug in the formulation.
While simple milling or spray drying of the drug will often suffice, more
advanced methods are sometimes necessary [5]. Another method to improve
dissolution is by formulating the drug in a more energetic (disordered) solid
state, such as an amorphous state – though it is generally susceptible to stability
issues [6]. However, in solid dispersion formulations, a disordered solid state of
the drug can be stabilized while simultaneously increasing the drug surface area
[7]. The drug bioavailability requirements and concerns specific to the
medication scenario are determined by e.g. the relevant drug material or
combination of drug materials, the diagnosis, as well as both inter- and intra-
patient physiological variations [2,8]. With other factors to consider, such as
the targeted shelf life and cost of the formulation, it is obvious that a versatile
methodological palette to enhance oral bioavailability is necessary.
In this thesis, novel approaches are taken to improve the oral bioavailability
of poorly soluble drugs by means of electrospraying and bi-polar parallel nozzle
electroencapsulation techniques.
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Electrospraying is a method of dispersing a suitable bulk liquid into micro-
or nanodroplets by electrical forces [9]. The method can be used for the
production of crystalline or amorphous micro- or nanoparticles of a compound
dissolved to the electrosprayed liquid [10]. For electrosprayed particles of a
poorly water-soluble drug, dissolution is improved due to the large surface area.
Often more importantly, the dissolution properties can be significantly affected
by the drug solid state, i.e. its crystallinity and polymorphic form [5,11]. The
amorphous form often exhibits far better dissolution properties, as compared
to the known crystalline polymorphs [12,13]. But, the gains to the dissolution
properties can be nullified by the instability of the amorphous state [6]. In the
present work, a novel stable polymorphic form of piroxicam was produced by
electrospraying microparticles of the drug. The discovery presented
electrospraying as a potential crystal engineering approach to improve the
dissolution rate of a drug to a degree, while retaining a high stability [14,15].
The main focus of the present work was in investigating and optimizing bi-
polar parallel nozzle electroencapsulation as a single-step method to produce
formulations of solid, functional drug carrier microparticles that would be
chemically inert, physically stable, as well as mechanically durable, handleable,
and dosable. The purpose was to potentially enhance the oral bioavailability of
poorly soluble or otherwise problematic drug materials by means of stabilizing
and shielding the disordered drug dispersion, and thus retaining the improved
dissolution properties until its pH-controlled release at the optimal drug
absorption site.
The principle of the electroencapsulation technique was to impact
oppositely charged electrosprayed droplets, which mutually attract due to
Coulombic forces. From the combined droplets, two types of drug carrier
particles were obtained after excess solvent evaporation: core-shell
microcapsules consisting of a glycerol core and a solid Eudragit E 100 polymer
shell, and solid Eudragit L 100 polymer micromatrix particles. As the
micromatrix particle payload, a poorly soluble model drug was dissolved to the
electrospraying liquid, and the drug was enveloped in the particles as a stable,
disordered solid dispersion. Alternatively, the drug was pre-loaded into micro-
or nanoparticulate mesoporous silicon (PSi), in itself a promising candidate for
an orally administrable drug carrier material [16–18]. The PSi particle payload
was then electroencapsulated as non-agglomerated dispersions in the
micromatrix particles, or microcapsule cores. The electroencapsulated drug
carrier particles were characterized. The drug dissolution and permeation
3
performances were evaluated in vitro for the micromatrix particles. Finally,
optimization of the electroencapsulation process parameters was considered in
particular for the asymmetric core-shell microcapsule production. In the
following paragraphs, the motivation and objectives for the experimental work
in each individual paper are specified and summarized briefly.
A variable geometry bi-polar parallel capillary electrospraying device was
designed and constructed for the electroencapsulation experiments, and
introduced in paper I. The design was based on a previously built
electrospraying device, which was used in paper II.
A substantial groundwork was conducted to select the materials for the
electroencapsulation experiments. Suitable electroencapsulation parameters
such as geometry, liquid flow rates Qi, and electrospraying voltages Ui, were
mapped for a wide range of electrospraying liquid compositions, consisting of
different combinations of various solvents, polymers, and additives. As a result,
two types of promising carrier particles were produced by electroencapsulation
and characterized in paper I: firstly, core-shell microcapsules, with an Eudragit
E 100 polymer shell that dissolves in the stomach pH conditions, and PSi
micro- or nanoparticles dispersed in a liquid glycerol core; and secondly, solid
micromatrix particles with griseofulvin loaded PSi nanoparticles dispersed to
an enteric polymer (Eudragit L 100) matrix.
During preliminary electrospraying experiments by Dr. Maija Nyström for a
previous work [13], partially crystalline particles, of which the X-ray diffraction
(XRD) patterns could not be identified, were produced by electrospraying a
chloroform solution of piroxicam. The unknown crystalline phase was highly
reproducible by electrospraying, but could not be produced by any attempted
alternate methods, such as exposing a chloroform solution of piroxicam to a
strong electrical field in an evaporation dish. The finding raised questions as to
whether a novel polymorphic form of piroxicam had been discovered by
electrospraying. The purpose of paper II was to answer these questions:
partially crystalline particles, with the crystalline phase of the suspected new
polymorphic form of piroxicam, were produced in various electrospraying
conditions, characterized extensively with emphasis on XRD methods, and
monitored for stability considerations.
A larger electroencapsulation chamber design was introduced in paper III.
The purpose was to improve the electroencapsulation collection efficiency, and
to enhance the solvent evaporation from the produced droplets, microcapsules
and micromatrix particles without the necessity of additional air flow, excessive
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heating, or depressurization. In paper III, further investigation was conducted
on the electroencapsulation of griseofulvin and griseofulvin loaded PSi
nanoparticles in Eudragit L 100 polymer micromatrix particles as solid
dispersions. Controlled dissolution and permeation properties of the
electroencapsulated griseofulvin were evaluated in vitro, and compared to the
performance of free griseofulvin. The stability of the micromatrix particles was
monitored in accelerated conditions over a period of six months.
The work in paper IV was focused on the optimization of the bi-polar
parallel nozzle electroencapsulation process in the production of Eudragit
E 100-glycerol core-shell microcapsules with a PSi nanoparticle payload. The
significance of ten different electroencapsulation parameters (factors) on the
measured electroencapsulation process quantities, such as capsule yield and
composition, was evaluated in a coarse fractional factorial experiment (FFE).
The purpose was to identify the important factors, and to draft a general
strategy for optimizing the efficiency of any electroencapsulation process of a
similar type. Additional examination of the electroencapsulation process
efficiency was performed by sweeping the core liquid flow rate Qc, and
comparing relevant electroencapsulation process quantities with the measured
electrosprayed droplet size and charge distributions.
5
2. Background and Theory
2.1. Electrostatics
Electrostatics is the science of static electrical charges – charges that are at rest
relative to the observer, or closely so. A configuration of static charges
constitutes an electrostatic system, or a system at electrostatic conditions. With
such a system at (near) equilibrium, all electric currents, magnetic fields due to
moving charges, and interactions of charges with external magnetic fields can
be considered to be negligible for the observer [19]. Electrostatic phenomena
stem from the interactions between static charges and/or charged bodies [20].
2.1.1. Electric charge
The electric charge q is a quantized fundamental property of elementary
particles. Charge can be positive or negative: the charge of a proton is equal to
the elementary charge e, while that of an electron is –e. A neutron carries zero
charge, and is therefore electrically neutral. In a (conceptually) isolated system,
net charge is conserved. In 1909, the value of e was first measured to an
accuracy of 1% by Robert A. Millikan and Harvey Fletcher, using the oil-drop
method which Millikan continued to refine [21].
2.1.2. Electrostatic Force







� ��� , (1)
where Fij is the force exerted on point charge qi by point charge qj, and
��� = ��� − ��� ��� − ����  is the unit vector distance between the charges. A
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manifestation of the fundamental electromagnetic force, the electrostatic force
can be presented as an abstract field. At a given point r, the net electric field E(r)
due to a static charge distribution simplifies to
�(�) = �(�) ��⁄ , (2)
where F(r) is the net electrostatic force exerted on a stationary test charge q0 at
point r by the external charge distribution. As seen from Equation 1, the
electrostatic force between two charges of different signs is attractive, and the
force between two charges of the same sign is repulsive.
Analogous to the electrostatic force is the fundamental gravitational force
which obeys the inverse-square law of gravity, obtainable from Equation 1 for
point masses by making the following replacements: q  m (mass), and
1/4πε0  G (gravitational constant). However, negative mass has never been
observed, and only attractive gravitational forces have been proven to exist
outside theoretical considerations [22–24]. Magnitude comparison of these
forces reveals that in general, electrostatic force utterly dominates over
gravitational force in interactions between submicron (< 10−6 m) objects, with
the possible exceptions of neutral conductors or extremely condensed matter
close below this size limit. Matter is bound together at the atomic level by
electrostatic forces: electrons are attracted to the vicinity of atomic nuclei to
complete atoms [25]; atoms can bond together by electrostatic forces to form
molecules [26]; and finally atoms, ions, and molecules compose crystalline or
amorphous solids (Chapter 2.4.1). Generally, the relative importance of
gravitational attraction grows for more massive objects, in part because the
effects of charges of different signs cancel each other out, and in part because
the sustainable net charge density of a physical body is limited (cf.
Chapters 2.1.4.3–4). At astronomical scales (> 107 m), gravitational force
absolutely dominates over electrostatic force – celestial bodies and objects, such
as the Earth, the Milky Way, and the Laniakea, are held together by gravity [27].
At the extreme, the squeeze of gravitational force is able to transform matter
into a singularity [28].
The very existence of stable solid matter, including the human body, is
perhaps the most perceptible manifestation of electrostatic force. For an
inhabitant of the Earth, all tangible sensations originate from electrostatic
forces, with the sole exception of the downward acceleration induced on our
every bone by the constant gravitational pull of the planet’s combined mass. In
spite of the gravitational force, one is able to stand at rest on the planet’s surface
7
without collapsing or falling. This is owing to a fundamentally electrostatic net
normal force, pushing back from the ground on the bottoms of the recipient’s
feet (or equivalent). The interaction is relayed via connected hard and soft body
tissues, distributing to each cell of the body to uniformly balance the
gravitational force and thus counter the acceleration relative to Earth.
May the electrostatic force be with you as you read this book further, you
will need it.
2.1.3. Electric Potential
The concept of a scalar electric potential V is a useful tool in electrostatics. At
electrostatic conditions, where Equation 2 applies, the potential V at point r can
be defined as
�(�) = −∫ � ∙ d��� + ��, (3)
where V∞ is a constant. In the electrostatic case, the potential difference ∆V and
voltage U between two points are equal [19]. For a finite charge distribution, V∞
corresponds to V at infinity: limr  ∞ V(r) = V∞. In this book, V∞ defaults to 0 for
convenience.
2.1.4. Charge Transfer
As opposed to a single atom where all permitted electron energies are separate
and discrete, the energy levels of interacting atoms in a solid can be treated as
being split into energy bands of effectively continuous energy ranges [20,29].
The outer, most energetic electrons occupy the valence band, and excited
electron states form the conduction band.
In a conductor, the valence band is partially empty, or electrons overflow to
the conduction band which is connected to or overlaps with the valence band.
In such a solid, valence electrons are able to move into new energy states and
electrical conductivity is high. For an applied electric field E ≠ 0 in a conductor,
a net electron flow is generated and observed as an electric current [20,29].
In an insulator, the valence band is full, and in accordance to the Pauli
Exclusion Principle, electrons cannot move into new energy states. Therefore,
electrons in the valence band can transfer no charge. The conduction band is
empty and separated from the valence band by the forbidden band with very
few or no energy states. The conductivity of an insulator is low, and greatly
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depends on the density and mobility of ions; density of impurities, structural
defects, and molecular-ion traps that can generate localized energy states in the
forbidden band; as well as the band gap energy [20,29,30]. Semiconductor
materials have the insulator band structure but the band gap is relatively small,
so thermal or optical excitation of electrons is feasible [29].
An isolated charge distribution rearranges spontaneously until an
thermodynamic equilibrium configuration of the system is reached, equating to
a local potential energy minimum. Charge is redistributed within objects and
transferred between them by the realignment, relocation, and exchange of
charged particles, namely electrons or ions. For a conductor, where electron
movement is relatively unrestricted, any net charge accumulates to the surfaces
in electrostatic conditions, and surface charge density σ increases with positive
surface curvature [31]. The charge distribution is uniform for a spherical
conductor surface far from other charge.
Mechanisms of charge transfer between objects are determined by the
physical state, conduction properties, and charge density of both the interacting
objects and the medium, contacts between the objects, adsorbed layers on
object surfaces, and available charge carrier species. As an example, nearly all
objects in atmospheric conditions are covered by at least a monolayer of water,
an excellent solvent capable of containing an electric double layer [32]. A
moisture layer thus generally acts as a potential barrier for electrons to some
degree [33]. Consequently, various ions that dissolve to the water film from the
object surface can be significant surface charge carriers, especially for insulators
[20,32].
2.1.4.1. Contact and Frictional Charging
Contact charging (contact electrification), or charge transfer between objects
that are brought to a non-sliding contact and subsequently separated, is a
surface phenomenon that is satisfactorily explained by the electron energy band
model (Chapter 2.1.4.) only for two conductors with ideal, uncontaminated
surfaces. When brought to contact, a difference between the work functions of
the conductors drive a transfer of electrons that results in a repeatable contact
potential difference between the conductors [34]. At conductor separation, a
charge backflow occurs by electron tunneling, and cuts off when the distance
between closest points of separation exceeds about 1 nm [35,36]. Assuming that
the total charge remains constant, the backflow nearly equalizes the conductor
potentials. Thus, between two initially equipotential conductors, the full
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contact charging cycle results in a most often negligible net charge transfer.
However, accumulated contact charge can be significant in a large number of
small conductors, such as metal powders [37,38].
Contact charging is vastly more complicated when one or both of the
contacting objects are insulators, particularly so for dielectrics [39,40]. With an
insulator involved, contact charging generally results in a significant amount of
charge being transferred between the contacting objects [34,39,41]. For
insulators, the probability of electron transfer varies greatly with local surface
energy state density. The process could be quite energy selective, as determined
by the contacting material [30]. The amount of electron energy states involved
in the contact charging is further limited by the actual contact area, influenced
by surface roughness, macroscopic contact area and contact pressure [39]. Bulk
states close to the surface may contribute to electron transfer to a limited degree
[42]. Importantly, surface contaminations may give rise to an electric double
layer or mobile surface ions (Chapter 2.1.4.), potentially hindering electron
transfer and diminishing its significance in the charging, in favor of ion transfer
[20,32]. Charge can also be transferred by exchange of nano-sized bits of
material [41].
True contact charge is principally a material property in ideal conditions –
measured in a vacuum for a single contact of repeatable force and duration,
between uncontaminated surfaces of consistent shape and morphology.
Different materials can be arranged in triboelectric series according to the
tendencies to charge either positively or negatively when contact charged with
another, particular material [38,43]. As an extreme example, PTFE (Teflon)
charges negatively when rubbed against virtually any other material [38,44,45].
However in general, triboelectric series are not unambiguous [20,38]. Lately,
nanogenerators based on triboelectricity have been researched [46].
In real contacts, sliding occurs; surfaces are imperfect; and external variables
such as temperature T, moisture, pressure p, and atmospheric composition
cannot be ignored. To describe more realistic contacts, the term frictional
charging is used of charge transfer between two objects that rub against each
other. In frictional charging, the contact area is larger in at least one of the
objects as compared to contact charging, and generally more charge is
transferred [41,44]. Friction charging is less dependent on the materials, and is
sensitive to the size and shape of the rubbed objects and contact areas, rubbing
velocity, contact pressure, and contact temperature [20,47,48].
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2.1.4.2. Induction Charging
As explained by Michael Faraday after performing his famous ice pail
experiment in 1843, conductive materials can gain charge by induction [49].
Two processes of induction charging is demonstrated schematically in Figure 1
for an initially neutral sphere. Following the upper row of images in the figure
from left to right, the proximity of a charged object, in this case a positively
charged rod electrode, causes an induced charge separation within the sphere
due to electrostatic forces. Grounding the sphere at this configuration allows
for negatively charged electrons to enter the sphere from the ground to fill
vacant electron states. Equivalently, the vacancies can be considered as positive
charges which flow to the ground. This charge transfer, or induction charging
of the sphere, ceases at net force equilibrium. At that point the net charge of the
sphere has become negative, and remains so once the sphere is disconnected
from the ground.
Figure 1. Two processes of induction charging a sphere with an initial net charge qs = 0.
The illustrated states show charge distributions at equilibrium. The intermediate
arrows indicate the reversibility of the transitions, with the signs of any changes in qs
indicated. The two transitions that involve induction charging are highlighted with a
top-to-bottom vertical bar.
In another scenario, shown in Figure 1 (transition to the bottom row), the
sphere is first contact charged positively by bringing it to contact with the rod
electrode. In the bottom row sequence of the figure, additional positive charge
is subsequently transferred to the sphere by induction charging. A nearby
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ground electrode induces charge separation in the sphere and the connected
rod, with negative charge flowing from the sphere via the rod electrode circuit
to the ground. After separating the sphere from the rod, the sphere is left with a
net positive charge greater than that gained earlier from merely contacting the
rod.
Many electrostatics devices and measurement instruments, such as Faraday
cages, Faraday cups, electrometers and electric field meters, are based on
induced charge separation [49–51]. A simple coaxial induction probe is capable
of simultaneously measuring the charge, size and distance of a passing object
[52]. Under suitable conditions, charged droplets can be extracted from a body
of a sufficiently conducting liquid by induction charging the liquid surface.
This phenomenon is discussed in Chapter 2.2 (Electrostatic Atomization).
2.1.4.3. Corona Discharging
The maximum charge density of an object is limited by several phenomena. For
practical purposes, the most common limiting factor is the air breakdown
strength – the electric field strength required for air ionization, which is
approximately Emax = 3 × 106 V/m for air at normal pressure, with lowest values
observed for dry as compared to humid air [53–55]. Above this limit, electrons
accelerated in the electric field can gain enough energy between collisions to
detach another electron from atoms they collide with. Thus, avalanches of
ionizing electrons (Townsend avalanches) are formed in the breakdown region
[56]. If the electric field above the surface of a charged object exceeds the
breakdown limit, the surface is discharged via the ionized air. This limits the
attainable charge density of any surface exposed to an air atmosphere to a
maximum of σ = 2.6 × 10−5 C/m2, as obtained from Gauss’s law.
A corona discharge is a low-energy type point discharge that occurs in a
limited region of air or another ionizing gas next to an electrode of a high
positive curvature, if its associated non-uniform electric field locally exceeds the
breakdown strength of the gaseous medium [20,57,58]. Due to the ionization
(plasma formation) process, an aerial corona discharge emits a faint blue glow
and is thus traditionally dubbed St. Elmo’s fire among sailors and aircraft pilots
[59]. Charge is carried away from the corona discharge region and the sharp
corona electrode mostly by relatively slowly moving unipolar ions which share
the sign of the corona electrode. If the surrounding gas does not contain
enough electronegative atoms to capture the electrons ejected from a negative
corona discharge, it is also possible for slow electrons to remain a significant
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Two processes of induction charging is demonstrated schematically in Figure 1
for an initially neutral sphere. Following the upper row of images in the figure
from left to right, the proximity of a charged object, in this case a positively
charged rod electrode, causes an induced charge separation within the sphere
due to electrostatic forces. Grounding the sphere at this configuration allows
for negatively charged electrons to enter the sphere from the ground to fill
vacant electron states. Equivalently, the vacancies can be considered as positive
charges which flow to the ground. This charge transfer, or induction charging
of the sphere, ceases at net force equilibrium. At that point the net charge of the
sphere has become negative, and remains so once the sphere is disconnected
from the ground.
Figure 1. Two processes of induction charging a sphere with an initial net charge qs = 0.
The illustrated states show charge distributions at equilibrium. The intermediate
arrows indicate the reversibility of the transitions, with the signs of any changes in qs
indicated. The two transitions that involve induction charging are highlighted with a
top-to-bottom vertical bar.
In another scenario, shown in Figure 1 (transition to the bottom row), the
sphere is first contact charged positively by bringing it to contact with the rod
electrode. In the bottom row sequence of the figure, additional positive charge
is subsequently transferred to the sphere by induction charging. A nearby
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ground electrode induces charge separation in the sphere and the connected
rod, with negative charge flowing from the sphere via the rod electrode circuit
to the ground. After separating the sphere from the rod, the sphere is left with a
net positive charge greater than that gained earlier from merely contacting the
rod.
Many electrostatics devices and measurement instruments, such as Faraday
cages, Faraday cups, electrometers and electric field meters, are based on
induced charge separation [49–51]. A simple coaxial induction probe is capable
of simultaneously measuring the charge, size and distance of a passing object
[52]. Under suitable conditions, charged droplets can be extracted from a body
of a sufficiently conducting liquid by induction charging the liquid surface.
This phenomenon is discussed in Chapter 2.2 (Electrostatic Atomization).
2.1.4.3. Corona Discharging
The maximum charge density of an object is limited by several phenomena. For
practical purposes, the most common limiting factor is the air breakdown
strength – the electric field strength required for air ionization, which is
approximately Emax = 3 × 106 V/m for air at normal pressure, with lowest values
observed for dry as compared to humid air [53–55]. Above this limit, electrons
accelerated in the electric field can gain enough energy between collisions to
detach another electron from atoms they collide with. Thus, avalanches of
ionizing electrons (Townsend avalanches) are formed in the breakdown region
[56]. If the electric field above the surface of a charged object exceeds the
breakdown limit, the surface is discharged via the ionized air. This limits the
attainable charge density of any surface exposed to an air atmosphere to a
maximum of σ = 2.6 × 10−5 C/m2, as obtained from Gauss’s law.
A corona discharge is a low-energy type point discharge that occurs in a
limited region of air or another ionizing gas next to an electrode of a high
positive curvature, if its associated non-uniform electric field locally exceeds the
breakdown strength of the gaseous medium [20,57,58]. Due to the ionization
(plasma formation) process, an aerial corona discharge emits a faint blue glow
and is thus traditionally dubbed St. Elmo’s fire among sailors and aircraft pilots
[59]. Charge is carried away from the corona discharge region and the sharp
corona electrode mostly by relatively slowly moving unipolar ions which share
the sign of the corona electrode. If the surrounding gas does not contain
enough electronegative atoms to capture the electrons ejected from a negative
corona discharge, it is also possible for slow electrons to remain a significant
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charge carrier species outside the discharge region. Surfaces and particles can
gain charge or be neutralized in the electric field of a corona discharge by
attracting charge carriers it expels [20,60]. A corona discharge produces no
sparking, unlike more energetic point discharges such as lightning [58].
2.1.4.4. Other Mechanisms of Charging and Discharging
The electrical conductivity Κ of a liquid depends on its ion concentration and
ion mobility. For example, water is normally an excellent conductor of
electricity,  because even tap water contains an abundance of dissolved salts in
the form of ions such as Na+, K+, Ca2+, Mg2+, F−, and Cl−. However, ultra-pure
distilled water only contains relatively very few OH− and H3O+ ions due to
auto-dissociation of H2O, and is actually a poorly conducting, albeit arduous to
obtain, liquid [61]. In any dielectric liquid, dissociated ions form electric double
layers at the liquid interfaces, even when the liquid body is on average
electrically neutral [62]. Charging occurs in the liquid whenever any of the
liquid interfaces are disrupted [20]. Poorly conducting (Κ of 10−9–10−3 µS/cm)
or isolated liquids can hold a net charge, provided that the liquid contains or
obtains enough dissociated ions to store the charge [20]. Liquid bodies that
contain dissociated ions may deform in an external electric field, in order for
Coulombic forces to reach balance with other external forces and the liquid
surface tension.
As discussed in Chapters 2.1.4.1 and 2.1.4.3, free charge carriers such as
electrons, ions, or macroscopic charged particles can be produced by gas
ionization, or by mechanical detachment of material from charged objects. In
addition, such charge carriers can originate from, for example, nuclear
reactions that produce alpha or beta radiation [63], electron field emission [64],
electron photoemission [65], or solute and dispersed material left over from
evaporated charged liquid droplets [66].
In a gas atmosphere that contains free charge carriers, highly charged
objects disconnected from the ground and voltage sources tend to neutralize
over time when no external electric field is present. Coulombic attraction draws
nearby free carriers of oppositely signed charge into contact with the charged
object, and charge is transferred via contact to achieve electrostatic equilibrium.
On the other hand, particles or objects in a gas can also be charged by diffusion
charging, due to random collisions with ions in thermal motion that have
sufficient kinetic energy to overcome the Coulombic potential energy barrier of
the particle or object in question. Diffusion charging can become significant for
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particles of ca. 3 µm or smaller in size. In principle, charge can build up to the
discharge limit by diffusion charging [20]. For notably larger objects, an
equilibrium charge is reached when charge transfer due to the opposing
mechanisms balance each other out.
In vacuum, the maximum charge density of an object is ultimately
determined by the electron field emission limit (cf. Chapter 2.2.3). At the
material specific electron field emission limit, the electric field strength at the
surface of the object is sufficient for tunneling and subsequent emission of
electrons from the object [64,67]. Electron field emission has been proposed as
a method of spacecraft neutralization [68].
2.2. Electrostatic Atomization
Electrostatic atomization of a liquid, or breaking up a liquid into a jet of
charged droplets by electrical forces [62,69,70], is the foundational electrostatic
phenomenon for the present work. The technique is synonymously dubbed
electrospraying [9], electrostatic spraying [71], electrostatic dispersion [72],
electrically forced jets [73], electroatomization [74], electrohydrodynamic (EHD)
atomization, or liquid atomization by electric means [69]. Electrospraying was
discovered in as early as 1750 when Abbé Jean-Antoine Nollet, an esteemed
French experimental phycisist and clergyman, experimented with
electrospraying of water and various liquors, and reported his observations
[75,76]. As the story goes, he noticed that if a person was to cut himself while
being electrified by a high-voltage generator, he would not bleed normally.
Instead, blood would spray from the wound (due to electrical forces) [62]. First
modern scientific studies on electrospraying were conducted in 1915 by J.
Zeleny [77,78]. In 1964, the physics of electrospraying were established by G. I.
Taylor [79].
2.2.1. Principles of Electrospraying Apparatus
In Figure 2, a simple electrospraying apparatus is shown schematically. Liquid
is driven at a controlled volume flow rate Q through a conducting capillary,
typically of an inner diameter di of 0.1–1 mm. The capillary is kept at a positive
or negative high potential and thus doubles as a high voltage electrode. A
controlled voltage U between the electrospraying nozzle and a nearby ground
electrode (extractor) generates an electric field which powers the
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electrospraying process – charge is induced to the tip of the liquid column
outside the nozzle. Due to electrical forces overcoming the surface tension of
the liquid, a droplet detaches directly from the meniscus, or a jet elongates from
the meniscus and promptly disintegrates into droplets. In sustained
electrospraying, a steady liquid flow from the capillary replenishes the
meniscus, and the cycle repeats at a high frequency, or a continuous jet is
retained. The electrosprayed droplets are induction charged, sharing the sign of
the electrospraying electrode. Thus, the electrosprayed droplets accelerate in
the cylindrically symmetric external electric field. At very high droplet
formation frequencies, the droplets are self-dispersing due to mutual
Coulombic repulsion. In the electrospraying process, the total surface area of
the liquid increases as bulk liquid is disintegrated into droplets by the electric
field. Energy drawn from the electric field is therefore converted to liquid
specific energy related to its surface area; kinetic energy and potential energy of
the charged droplets; and heat [62,80].
Figure 2. Schematic of a basic electrospraying device. For the shown dimensions, the
liquid flow rate Q for a single nozzle is typically of the order of 0.1–1 ml/h and the
electrospraying voltage U up to several kilovolts, depending on the electrosprayed
liquid properties and the electrospraying mode. The droplet size �̅ distribution greatly
depends on the electrospraying parameters (Chapter 2.2.2) and varies across different
spraying modes.
For the electrospraying geometry of Figure 2, an open extractor electrode
centered at the symmetry axis allows for passage of the electrosprayed droplets.
The electric field uniformity can be controlled by leading the capillary through
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a guard plate (not shown in Figure 2), or a sleeve kept in reduced potential
[81,82]. The electric field is further shaped by the extractor electrode and the
electrosprayed droplets themselves. Droplet trajectories in the system are
determined dynamically by the electric field, gravity, ambient gas flow and
pressure p; as well as the droplet charge q, size d, and mass m. In basic
applications, for example in production of micro- or nanoparticles via
electrospraying, droplets are ordinarily neutralized post extraction
(Chapter 2.2.6), and collected on a grounded collector electrode (not shown in
Figure 2) below the extractor electrode [10,83,84]. The distance to the collector
determines the air time of electrosprayed droplets, which in addition to
ambient gas flow, pressure p, and temperature T is important for controlling
the degree of excess solvent evaporation from the droplets en route to the
collector.
The electrosprayed liquid can be deployed to an electric field in various
ways. In addition to the electrostatic pressure, liquid flow to the electric field
can be driven by hydrostatic pressure, gravity, capillary pressure, or a
centrifugal force [85]. The shape of the interface (point, line or surface)
between the liquid body and the external electric field is essential in establishing
the atomization geometry. For axial electrospraying from a point source, the
liquid is commonly deployed using a capillary nozzle as depicted in Figure 2
[9,13,69,70,86,87]. It is also possible to drive the liquid through a simple hole in
the container holding the liquid [88,89]. The liquid can alternatively flow on
the outer surface of a wettable, positively curved solid surface, where the
external electric field intensifies towards the tip [90–92]. Point sources such as
these can be arranged into arrays, with shared or separate liquid reservoirs, in
order to increase the total electrospray yield and robustness [89,91,93–102].
Alternative ways to scale up the process include nozzle geometry modification,
for instance by using an extender cap [103]; or electrospraying radially from a
line source, such as the edge of a plate [104], or a rotating disc [105,106]. A
porous foam cylinder (or a similar network of edges) can effectively be utilized
as an array of line sources [62]. Liquid-in-liquid electrospraying systems have
been deployed as well, where the dynamical effect of an insulating surrounding
liquid of low viscosity η is neglectable on the electrospray [107]. In such
systems, the atomized liquid can be driven through a large area membrane filter
for a scaled up yield [108,109]. Finally, electrostatic atomization can take place
directly from a free large area liquid surface [110].
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a guard plate (not shown in Figure 2), or a sleeve kept in reduced potential
[81,82]. The electric field is further shaped by the extractor electrode and the
electrosprayed droplets themselves. Droplet trajectories in the system are
determined dynamically by the electric field, gravity, ambient gas flow and
pressure p; as well as the droplet charge q, size d, and mass m. In basic
applications, for example in production of micro- or nanoparticles via
electrospraying, droplets are ordinarily neutralized post extraction
(Chapter 2.2.6), and collected on a grounded collector electrode (not shown in
Figure 2) below the extractor electrode [10,83,84]. The distance to the collector
determines the air time of electrosprayed droplets, which in addition to
ambient gas flow, pressure p, and temperature T is important for controlling
the degree of excess solvent evaporation from the droplets en route to the
collector.
The electrosprayed liquid can be deployed to an electric field in various
ways. In addition to the electrostatic pressure, liquid flow to the electric field
can be driven by hydrostatic pressure, gravity, capillary pressure, or a
centrifugal force [85]. The shape of the interface (point, line or surface)
between the liquid body and the external electric field is essential in establishing
the atomization geometry. For axial electrospraying from a point source, the
liquid is commonly deployed using a capillary nozzle as depicted in Figure 2
[9,13,69,70,86,87]. It is also possible to drive the liquid through a simple hole in
the container holding the liquid [88,89]. The liquid can alternatively flow on
the outer surface of a wettable, positively curved solid surface, where the
external electric field intensifies towards the tip [90–92]. Point sources such as
these can be arranged into arrays, with shared or separate liquid reservoirs, in
order to increase the total electrospray yield and robustness [89,91,93–102].
Alternative ways to scale up the process include nozzle geometry modification,
for instance by using an extender cap [103]; or electrospraying radially from a
line source, such as the edge of a plate [104], or a rotating disc [105,106]. A
porous foam cylinder (or a similar network of edges) can effectively be utilized
as an array of line sources [62]. Liquid-in-liquid electrospraying systems have
been deployed as well, where the dynamical effect of an insulating surrounding
liquid of low viscosity η is neglectable on the electrospray [107]. In such
systems, the atomized liquid can be driven through a large area membrane filter
for a scaled up yield [108,109]. Finally, electrostatic atomization can take place
directly from a free large area liquid surface [110].
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2.2.2. Electrospraying Mode Characteristics
Electrostatic atomization can be conducted in different modes, as determined
by the electrospraying parameters such as liquid properties (conductivity Κ,
density ρ, viscosity η, surface tension γ); liquid flow rate Q; electric field
strength E at the liquid surface, which in turn is influenced by the atomization
geometry and voltage U; other external forces acting on the liquid surface, such
as gravity or centrifugal forces; as well as atmospheric gas composition,
humidity, flow velocity, pressure p, and temperature T [62,70,71,105,111–116].
As many as over ten different spraying modes can be identified, characterized
by the shape and stability of the liquid meniscus, presence and permanence of
continuous jets, rate of droplet formation, as well as electrospraying current
characteristics [9,69,70,111,112,114–117]. The size and charge distributions of
atomized droplets depend primarily on the spraying mode, and secondarily on
the atomization parameters within that mode [70,74,111,112,116,118].
With no applied voltage (|U| = 0) in an electrospraying device of a fixed
geometry (e.g. that of Figure 2), operated at constant T and p on Earth’s surface
with the gravity field aligned to the electrospraying axis, liquid flowing at a rate
Q > 0 accumulates to a drop that hangs outside the capillary (Figure 3a).
Assuming that evaporation rate W from the hanging drop remains lower than
Q, the drop grows periodically to a critical size, above which the drop weight
surpasses the surface tension that binds the drop to both the capillary and the
liquid column inside the capillary. The essentially neutral drop is then detached
from the capillary due to gravity, and accelerated in the gravity field.
At zero gravity and low liquid momentum, the capillary does not drip liquid
if no other force to drive the liquid is present. Instead, the liquid wets the
capillary exterior surface, and proceeds to gradually engulf the device up to a
balance point, where total evaporation W = Q.
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Figure 3. Characteristics of the liquid meniscus, jet, and sprayed droplets for selected
electrostatic atomization modes, shown schematically: a) no electrification (reference),
b) dripping mode, c) microdripping mode, d) cone-jet mode, and e) multi-jet mode.
The atomization voltage |U| is increased through figures a–e, with all other
electrospraying parameters kept constant. These and other electrospraying modes are
sketched, imaged and described extensively in literature
[12,70,71,81,111,112,116,119,120].
2.2.2.1. Dripping and Microdripping Modes
With a low voltage |U| applied, the surface of the liquid protruding from the
capillary is charged by induced charge separation, and Coulombic forces act on
the charged surface of the liquid meniscus, adding to the effect of gravitational
force exerted on the liquid. As depicted in Figure 3b, with |U| > 0, droplets still
detach one by one, but do so at an increased rate in addition to being both
smaller and charged by induction, as compared to scenario of Figure 3a. The
liquid meniscus contracts and is swiftly replenished by new liquid after each
droplet detachment. Detached droplets are then accelerated by the electric field,
which quickly becomes the dominant force acting on the droplets in between
the electrodes as |U| is increased. With no radial repulsive forces from
neighboring droplets, each droplet follows roughly the same trajectory. This
simple form of electrospraying is known as the dripping mode, or descriptively
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as field-enhanced dripping. In this mode, with increasing |U|, the dripping
frequency increases (up to hundreds of Hz), the electrosprayed droplets get
smaller and the droplet specific charge q/m increases [62,69,70].
At a sufficiently high |U|, and low Q, it is possible, at least for droplets of
liquids such that Κ < 10-2 µS/cm, to become smaller than the inner diameter of
the nozzle (d < di) while the electrospray remains in the pulsating regime
[69,70,111]. Such small droplets can form at frequencies of up to tens of kHz,
and the liquid meniscus no longer contracts between droplet detachments
[69,70,111]. Below this arbitrary droplet size limit, the electrospray is said to
transition into microdripping mode (Figure 3c) [69,70,111].
Droplets electrosprayed in dripping or microdripping mode are quite
consistent in size, with median droplet size typically in the range of a few µm to
about 1 mm [70,111]. Following each event of electrospraying a main droplet,
several magnitudes smaller and highly charged satellite droplets are ejected
from both the meniscus and the main droplet due to vibrations and surface
instabilities of the liquid objects. Satellite droplets move slowly, evaporate
quickly and do not contribute significantly to the volume of electrosprayed
liquid. However, satellite droplets are capable of carrying a significant portion
of the electrosprayed charge (see Chapter 2.2.3) [121–123].
Dripping and microdripping modes of electrospraying can be used for
controlled deposition of microdroplets [124,125] – for instance microscale
EHD inkjet printing in which droplet detachment frequency can be regulated
by using pulsating voltage (droplet on demand) [126,127]. These modes have
also been used in microencapsulation of biotic or other type of materials
[128,129].
2.2.2.2. Cone-Jet Mode
The most important electrospraying mode is the cone-jet mode (CJM), as
judged by the amount of research and applications associated with it
[9,10,118,130–138,13,62,71,83,84,86,91,113]. The (stable) CJM is characterized
by the steady axisymmetrical conical shape assumed by the liquid meniscus,
which in this mode is often dubbed the Taylor cone [71,90,111,132,138]. The
Taylor cone can be straight-sided, concave or convex depending on the polarity
and magnitude of U, the electrospraying geometry, and liquid properties [111].
As depicted in Figure 3d, in CJM a fine, stable, and continuous liquid jet is
ejected from the apex of the Taylor cone. Forces acting on the highly charged
surface of the jet cause varicose instabilities due to which the jet quickly
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disintegrates into very small (typically d = 0.1–100 µm) main droplets of a
remarkably narrow size distribution, accompanied by a host of much finer
satellite droplets; all of which are charged by induction
[9,74,83,112,136,138,139]. The main droplets form at a very high frequency
(from a few kHz up to several MHz) [70,118], and constitute nearly the entirety
of the electrosprayed liquid volume [71,132,136,140]. The thusly dense jet
disperses due to mutual Coulombic repulsion of the charged droplets [141,142].
As with dripping modes, the charge carried by satellite droplets can be relevant,
however [140].
The CJM is initiated for applicable liquids in suitable conditions (details
discussed in Chapter 2.2.4) when |U| is increased from the (micro)dripping
mode regime to the CJM onset voltage |Uc| [71,86,111,112]. Transition to the
CJM can be very distinct in some cases, whereas in others, an intermediate
pulsating mode may emerge amidst the transition from dripping mode to a
stable CJM (Chapter 2.2.2.3). As the electrospray enters CJM, the liquid
meniscus assumes the stable Taylor cone form, and both the atomization
current I and droplet frequency increase abruptly [83,112,143,144]. In CJM, the
measured I for a single Taylor cone is typically in the order of 10–100 nA
[71,144,145]. As |U| is increased within the CJM regime, the Taylor cone
remains stable but contracts axially. Simultaneously, the electrosprayed droplet
size decreases and droplet charge increases, albeit to a comparatively
insignificant degree (Chapter 2.2.4). The CJM voltage regime is affected by a
weak hysteresis effect – once initiated, CJM is maintained even if |U| is
decreased slightly below the original onset level |Uc| [71,131,136,146].
Additional control to the electrosprayed liquid volume can be gained by single-
event electrospraying, utilizing very low flow rates and pulsed voltages with a
stepping high enough to bypass the hysteresis effect [147].
Many applications have been found to benefit from the bottom-up
miniaturization among other useful properties that accompany electrostatic
atomization in CJM. The technique can be used for the production of micro-
and nanoparticles as small as a few nanometers in size [10,12,136,139,148,149],
including particles composed of pharmaceutical materials for the purpose of
preparing or manufacturing drug delivery systems (see also
Chapters 2.2.5 and 2.4) [83,84,134,150–154]. Other biomedical applications
include e.g. a handheld electrospray gun [137]. In EHD printing applications,
high resolution patterns down to tens of nanometers in size can be achieved
[155,156]. Painting similarly benefits from the attainable fine and uniform
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as field-enhanced dripping. In this mode, with increasing |U|, the dripping
frequency increases (up to hundreds of Hz), the electrosprayed droplets get
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liquids such that Κ < 10-2 µS/cm, to become smaller than the inner diameter of
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Taylor cone can be straight-sided, concave or convex depending on the polarity
and magnitude of U, the electrospraying geometry, and liquid properties [111].
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pigment coatings [10,86,157,158]. In crop spraying, the sprayed fine and
charged droplets spread effectively on the surfaces of plants and pest, reducing
the amount of pesticide or herbicide necessary for the desired effect
[62,159,160]. CJM electrospraying is being utilized in nanotechnology for thin-
film deposition with layer thickness down to the nanoscale [161,162]. By layer-
by-layer deposition (electrospray forming), composite bulk materials can be
produced [143,163–165]. The CJM is the most efficient mode for ion
production [116], and therefore the CJM ionization is utilized for mass
spectrometry [166], and miniaturized spacecraft propulsion technology
[91,167]. Quenching of a liquid-metal Taylor cone has been proposed for
regeneration of electron field emission cathode tips in spacecraft neutralizers
[68]. Encapsulation by electrospraying in CJM in order to produce micro- or
nanosized capsules will be discussed in Chapter 2.3 (Electroencapsulation).
2.2.2.3. Other Modes
In the transition voltage regime between dripping mode and CJM, a number of
intermediate pulsating modes may be observed depending on the
electrospraying parameters. These modes include the spindle mode (or burst
mode), in which the meniscus ejects elongated chunks of liquid that
disintegrate into comparatively large droplets of wide size distribution
[69,111,116]; the multi-spindle mode [111]; the intermittent or pulsed cone-jet
mode, which produces a non-continuously operating CJM [69,70,112,116]; the
oscillating jet mode [111]; and the precession mode [168]. In the last two modes,
the jet oscillates in a plane or rotates around the electrospraying axis,
respectively. As a result of these instabilities, the droplets produced in
oscillating or precession jet modes are not as fine or monodisperse as in CJM
[111].
As |U| is increased sufficiently in the CJM regime, kink instabilities and
multi-jet instabilities are introduced to the apex of the Taylor cone in addition
to the varicose instabilities which are always present in CJM. As a result,
different series of mode transitions may be induced to the electrospray,
depending on the atomization parameters. Firstly, with increasing |U| the jet
may become skewed and unstable (e.g. whipping) while remaining continuous
[111], before eventually entering a multi-jet mode (Figure 3e) with up to 8 jets
protruding from the meniscus [111,112,157,169]. From the multi-jet mode,
especially in low pressure conditions, the electrospray may gradually enter rim
emission mode – a mode similar to the multi-jet mode but without an
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observable meniscus. Eventually with increasing |U|, the electric field strength
becomes sufficient for atmospheric breakdown [69,170]. Instead of multi-jet
mode and rim emission, it is possible to experience a transition from CJM to a
pulsating, low frequency droplet ejection mode as |U| is increased, especially in
atmospheric pressures and for liquids of high γ [69,170]. Moreover, the
occurrence of a continuous corona breakdown while within the CJM regime
may lead to a transition to the space charge controlled regime of the Taylor
cone, considered to be a separate Delft aerosol generator (DAG) sub-mode, or
corona-assisted cone-jet mode. The poorly understood DAG mode is similar to
the CJM, but requires a stabilizing corona discharge, yields an higher droplet
generation frequency (on the order of 100 MHz), and thus results in extremely
small droplets being generated (ca. 1 µm) [69,138,171]. As an alternate
transition path, even at voltages |U| below the CJM regime, the electrospray can
enter the simple-jet mode when Q is sufficiently high [69]. The critical value of
Q for this mode is decreased with increasing |U| [69,112]. Eventually, as |U| is
increased within the simple-jet mode, it is possible to trigger a ramified jet
mode (cone-ramified jet mode) [112].
As compared to the CJM, the discussed higher modes and transition modes
of atomization display a larger droplet size, wider droplet size and charge
distributions, and irregular jet behavior (with the exception of DAG mode).
The practical uses of these modes are therefore relatively scarce, and not
considered further here.
2.2.3. Droplet Charge
At electrostatic conditions, the net charge of an isolated droplet is uniformly
distributed across its surface. Consequently, an electrostatic outward pressure is
exerted on the droplet surface due to repulsive Coulombic forces. At the same
time, the droplet is contracted and held together by an inward pressure due to
the liquid surface tension. The droplet becomes unstable if its charge q is
increased to the limit where these opposing forces are balanced. In 1882, Lord
Rayleigh derived stability conditions for a slightly deformed, charged droplet of
radius r and liquid surface tension γ [172]. He predicted that at the Rayleigh
limit droplet charge
�� = 8������� (4)
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to the varicose instabilities which are always present in CJM. As a result,
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may become skewed and unstable (e.g. whipping) while remaining continuous
[111], before eventually entering a multi-jet mode (Figure 3e) with up to 8 jets
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especially in low pressure conditions, the electrospray may gradually enter rim
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becomes sufficient for atmospheric breakdown [69,170]. Instead of multi-jet
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occurrence of a continuous corona breakdown while within the CJM regime
may lead to a transition to the space charge controlled regime of the Taylor
cone, considered to be a separate Delft aerosol generator (DAG) sub-mode, or
corona-assisted cone-jet mode. The poorly understood DAG mode is similar to
the CJM, but requires a stabilizing corona discharge, yields an higher droplet
generation frequency (on the order of 100 MHz), and thus results in extremely
small droplets being generated (ca. 1 µm) [69,138,171]. As an alternate
transition path, even at voltages |U| below the CJM regime, the electrospray can
enter the simple-jet mode when Q is sufficiently high [69]. The critical value of
Q for this mode is decreased with increasing |U| [69,112]. Eventually, as |U| is
increased within the simple-jet mode, it is possible to trigger a ramified jet
mode (cone-ramified jet mode) [112].
As compared to the CJM, the discussed higher modes and transition modes
of atomization display a larger droplet size, wider droplet size and charge
distributions, and irregular jet behavior (with the exception of DAG mode).
The practical uses of these modes are therefore relatively scarce, and not
considered further here.
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distributed across its surface. Consequently, an electrostatic outward pressure is
exerted on the droplet surface due to repulsive Coulombic forces. At the same
time, the droplet is contracted and held together by an inward pressure due to
the liquid surface tension. The droplet becomes unstable if its charge q is
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Rayleigh derived stability conditions for a slightly deformed, charged droplet of
radius r and liquid surface tension γ [172]. He predicted that at the Rayleigh
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or above, the droplet is no longer able to recover its spherical form, i.e. the
droplet is unstable (cf. Chapter 2.2.5) [172]. Division of Equation 4 by droplet








where ρ is droplet density.
In experiments by various groups since Rayleigh’s work, electrosprayed or
otherwise electrified microdroplets have been consistently observed to carry at
most a charge close to qR or less [71,122,173,174]. The measured maximum
value of the ratio |q|/qR has frequently been reported to reside in the range of
0.7–0.8 for droplets electrosprayed particularly in CJM [74,118,121,140]. In
some cases involving for example low atmospheric pressures, high
temperatures or humidities, or a liquid of high γ (e.g. water,
γ = 73 mN/m [175]), the droplet charge may be limited by the breakdown
strength of air instead of droplet stability, and a corona discharge occurs before
the Rayleigh limit charge is reached [62,121,176]. Furthermore, electron
emission can be expected to occur when the electric field strength at the droplet
surface Es = q/4πε0r2 ≥ 9.9 × 107 V/m [177]. By substituting q with qR from
Equation 4, it is seen that electron emission could in principle limit the droplet
charge when the condition γ/r ≥ 2.2 × 104 N/m2 is fulfilled.
2.2.4. Properties of Electrospraying in Cone-jet Mode
The forces acting on the surface of the Taylor cone in stable CJM are outlined
in the force diagram of Figure 4. The principal forces driving the liquid are the
electrostatic force Fen and electric tangential force Fet (normal and tangential
electric stresses), acting on the induced surface charge (ions); and the
polarization force Fε (electric polarization stress), acting on polarized charge.
The resistant forces are composed of surface tension Fγ, and net viscous force Fη
(viscous stresses), which depend on the corresponding liquid properties γ and η
[9,80,111,132]. The forces acting on the Taylor cone liquid are often each
considered in terms of unit force per volume (force density). The role of gravity
ρg as an additional driving, resistant, or skewing force density is determined by
the alignment of the Taylor cone in relation to g. In Figure 4, gravity
contributes to driving the liquid. The liquid acceleration �̇ at any point in the
cone surface is obtained from �̇ = �∑�� ���⁄ , where
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∂ΣFi/∂V = ∂(Fen + Fet + Fε + Fγ + Fη)/∂V + ρg is the sum of force densities, and V
is volume. As a note, in certain derivations, the most convenient choice can be
to analyze the Taylor cone in a frame of reference that accelerates with the
liquid. To compensate, liquid inertia can be treated as an additional resistant
inertial force FI, with force density ��� ��⁄ = −��̇ , for the purpose of
obtaining a nominal force equilibrium FI + ΣFj = 0 in accordance to the
D’Alembert’s principle of inertial forces [9,80].
Figure 4. Left: Photograph of NaI-doped glycerol electrosprayed in CJM using a
stainless steel nozzle (di = 0.15 mm, do = 0.30 mm, Q = 0.50 ml/h, U = −3.75 kV,
CNaI = 0.50 mg/ml, Κ = 0.7 µS/cm, air atmosphere, T = 23°C, p = 1.0 bar, RH = 20%).
Right: Outlined force diagram of a liquid volume dV in the surface of a stable Taylor
cone, with ΣF showing the force sum. Approximate directions are given for Fε and Fη.
For clarity, force magnitudes are not drawn in exact proportions. The frame of
reference is fixed to the Taylor cone position.
Forces Fen and Fet that act on an ion at point r in the liquid surface are
consequence of the electric field Es(r) at the liquid surface (Equation 2). Es(r)
depends on the electrospraying geometry and potential; induced charge
distribution elsewhere in the Taylor cone surface; as well as the charge and
image charge distributions due to electrosprayed droplets in the surrounding
air [111,132]. The net force ΣFi acting on the liquid surface may require the
cone to assume various shapes depending on the electrospraying parameters
[111]. As in the example of Figure 4, the apex usually forms an underlying
angle which is close to the predicted Taylor angle of 49.3°, but for example a
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or above, the droplet is no longer able to recover its spherical form, i.e. the
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inertial force FI, with force density ��� ��⁄ = −��̇ , for the purpose of
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stainless steel nozzle (di = 0.15 mm, do = 0.30 mm, Q = 0.50 ml/h, U = −3.75 kV,
CNaI = 0.50 mg/ml, Κ = 0.7 µS/cm, air atmosphere, T = 23°C, p = 1.0 bar, RH = 20%).
Right: Outlined force diagram of a liquid volume dV in the surface of a stable Taylor
cone, with ΣF showing the force sum. Approximate directions are given for Fε and Fη.
For clarity, force magnitudes are not drawn in exact proportions. The frame of
reference is fixed to the Taylor cone position.
Forces Fen and Fet that act on an ion at point r in the liquid surface are
consequence of the electric field Es(r) at the liquid surface (Equation 2). Es(r)
depends on the electrospraying geometry and potential; induced charge
distribution elsewhere in the Taylor cone surface; as well as the charge and
image charge distributions due to electrosprayed droplets in the surrounding
air [111,132]. The net force ΣFi acting on the liquid surface may require the
cone to assume various shapes depending on the electrospraying parameters
[111]. As in the example of Figure 4, the apex usually forms an underlying
angle which is close to the predicted Taylor angle of 49.3°, but for example a
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high η can result in other stable values [69,86,161,178,179]. The Taylor cone is a
very dynamic system – on its surface, standing waves have been observed, and
can be linked to the jet varicose instabilities as well as oscillations or
perturbations in electrospraying current [180].
In both theoretical and practical CJM considerations, the characteristic flow
rate Q0, characteristic current I0, and characteristic jet diameter d0 are useful
abstract quantities in describing the properties of the Taylor cone and the
electrosprayed droplets [74,145]. These characteristic quantities are defined as
�� = ��� ��⁄ (6)
�� = �(�� �⁄ )� �⁄ (7)
�� = (���� ���⁄ )� �⁄ . (8)
As an example for ethanol (relative permittivity εr = 24.3, γ = 22.8 mN/m,
ρ = 0.789 g/cm3, and 1.4 × 10−3 µS/cm ≤ Κ ≤ 3 µS/cm [69,168,175,181–183]),
Equations 6–8 yield for the maximum Κ value: Q0 = 3.1 µl/h, I0 = 2.4 nA, and
d0 = 0.29 µm.
The EHD Reynolds number (or viscous dimensionless parameter) δη is
defined as the ratio of the characteristic axial bulk liquid velocity �� ���⁄  and
the radial perturbation propagation velocity by viscous diffusion in the liquid
jet η/ρd0 [74,80]:
�� = ��� ���⁄ . (9)
For ethanol (η = 1.20 mPas [183]), using Κ = 3 µS/cm, δη = 1.91 is obtained
from Equation 9.
The Taylor cone natural liquid flow rate is the minimum liquid flow rate
Qmin required for stable CJM operation, and depends on the nature of the
restrictive force which is determined by the liquid properties. It has been
estimated that if εrδη > 1, the cone-jet becomes unstable when Q < Qmin ≈ εrQ0,
where Q0 and δη are obtained from Equations 6 and 9, respectively, due to a
negative polarization force Fε in the cone-jet region, or charge separation
[80,119,184]. However, experimental data indicates that the minimum flow rate
can be closer to Qmin ≈ 0.01 × εrQ0 in some cases, which is a result of deviation
between the assumed and measured values of the force ratio |Fε|/|Fen| [80]. For
liquids of εrδη < 1, viscous forces cause a loss of stability below Qmin ≈ Q0/δη
[80,183]. The estimate Qmin is susceptible to variations of Κ, as reported values
of Κ may span several orders of magnitude due to variations in solvent purity
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or other measurement conditions. This is noticeable from the presented range
of Κ literature values of ethanol, for example [69,168,181,182]. Within this Κ
range of ethanol, the estimate Qmin = εrQ0 = 0.07 ml/h (obtained for Κ = 3 µS/cm
[168]) reasonably covers the reported experimentally operated Q ranges of
ethanol in CJM [81,144]. Generally, Κ increases rapidly as solutes or impurities
are introduced to a poorly conducting liquid. Therefore, the approximation
method for the limit Qmin remains meaningful in the lower conductivity range
(Κ << 1 µS/cm) only if Κ is carefully measured for electrospraying formulations
that consist of such liquids.
2.2.4.1. Liquid prerequisites
In determining whether a liquid is electrosprayable, arguably the most
important liquid properties are electrical conductivity Κ and surface tension γ
[71,185]. Together with the density ρ, viscosity η, and relative permittivity εr of
the liquid, these properties determine the feasibility of the liquid for
electrospraying, and influence the properties of electrosprayed droplets, as
discussed throughout Chapters 2.2.2–4 [9,69]. In general, explicit limits for the
liquid properties cannot be determined because of mutual dependencies.
Normally, the parameters cannot be adjusted independently. For example, the
conductivity Κ of many liquids can be enhanced by increasing the solution
salinity [94,130,186]. Furthermore, γ can be decreased by introducing
surfactants to the liquid [187]. However, such additives usually influence other
liquid properties to some degree, as well.
For a liquid to be electrosprayable in CJM, Gañán-Calvo et. al. propose that
charge must be dynamically distributed to a thin layer at the surface of the
Taylor cone [74]. As approximated by the authors, for the bulk of the Taylor
cone to remain quasi-neutral, the condition
� ≫ 4�� �����⁄ (10)
must apply, where L0 and R0 are the characteristic length and radius of the jet,
respectively; and ε = εrε0 is the liquid permittivity [74]. As an example, for
typical electrospraying conditions of paraffin (Q = 4 ml/h, L0 = 1 mm, and
R0 = 30 µm), the authors obtained the experimentally verifiable coarse
condition of Κ >> 1 × 10−3 µS/cm from Equation 10  [74].
Directly observed estimates of the minimum Κ requirements for stable CJM
mode electrospraying in the air vary between 10−4–10−7 µS/cm for different
experimental conditions [71]. On the other hand, CJM has been reported for
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high η can result in other stable values [69,86,161,178,179]. The Taylor cone is a
very dynamic system – on its surface, standing waves have been observed, and
can be linked to the jet varicose instabilities as well as oscillations or
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abstract quantities in describing the properties of the Taylor cone and the
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�� = ��� ��⁄ (6)
�� = �(�� �⁄ )� �⁄ (7)
�� = (���� ���⁄ )� �⁄ . (8)
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�� = ��� ���⁄ . (9)
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of Κ may span several orders of magnitude due to variations in solvent purity
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or other measurement conditions. This is noticeable from the presented range
of Κ literature values of ethanol, for example [69,168,181,182]. Within this Κ
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ethanol in CJM [81,144]. Generally, Κ increases rapidly as solutes or impurities
are introduced to a poorly conducting liquid. Therefore, the approximation
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liquid properties cannot be determined because of mutual dependencies.
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respectively; and ε = εrε0 is the liquid permittivity [74]. As an example, for
typical electrospraying conditions of paraffin (Q = 4 ml/h, L0 = 1 mm, and
R0 = 30 µm), the authors obtained the experimentally verifiable coarse
condition of Κ >> 1 × 10−3 µS/cm from Equation 10  [74].
Directly observed estimates of the minimum Κ requirements for stable CJM
mode electrospraying in the air vary between 10−4–10−7 µS/cm for different
experimental conditions [71]. On the other hand, CJM has been reported for
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values of Κ as high as 103 µS/cm when electrospraying a liquid of low γ, and jet
diameters are considered to be of the order of 10 nm for liquids of Κ in the
order of 104 µS/cm [71,119]. The CJM regime generally shifts toward lower Q
with increasing K (cf. Equation 6) [71]. Some authors have proposed that no
upper limit of K for CJM exists per se, but instead the produced droplets
become so small that detecting them by light scattering becomes increasingly
difficult [146].
If γ is high enough, emergence of a corona discharge at the tip of the liquid
meniscus becomes probable, which destabilizes or prevents CJM
electrospraying in air [71,82,171]. A maximum value of as low as γ ≤ 50 mN/m
has been reported for stable CJM electrospraying [146]. On the other hand,
accounts of successful experiments of electrospraying glycerol (γ = 63 mN/m),
and even water (γ = 73 mN/m) in CJM set the maximum γ limit higher
[69,78,87,111,175]. The lowest observed limit values of γ are likely consequence
of unsuitable electrospraying parameter combinations, influenced decisively by
the high γ. When the electric field strength Es at the surface of the liquid
meniscus apex surpasses the breakdown strength of the surrounding gas, a
Corona discharge is triggered at the liquid apex. The occurrence of such an
event naturally depends not only on γ, but on various parameters. The
electrospraying geometry crucially affects the susceptibility of Es to the size or
shape variations of the meniscus, such as contraction, elongation, or varicose
and kink perturbations. The nozzle diameters di and do together with the liquid
wetting properties determine the width of the meniscus base, which affects the
meniscus length. Therefore, di and do influence the distance of the liquid apex
from the counter electrode, and thus Es at the liquid apex. With increasing Κ,
charge conducts to the liquid surface at a higher rate, and the jet is driven
increasingly more by normal forces as opposed to tangential stress, which leads
to more frequent and forceful surface disruptions. Consequently, local
variations of Es develop, which effectively decreases the Corona discharge
threshold value of γ [10,82]. An often used methodology to circumvent Corona
discharging is smoothing of sharp edges at the nozzle tip and application of a
downward flow of insulating sheath gas, such as CO2, around the sharp liquid
apex to cover it [82,115,171,186,188].
Many common solvents and oils, such as ethanol, chloroform, ethylene
glycol, acetone, and glycerol are readily electrosprayable in CJM over a
relatively wide range of electrospraying parameters [78,111,133]. Other liquids,
such as various vegetable oils, may require additives to adjust the liquid
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properties, such as K or γ [74,189]. However, establishing a stable CJM on
water is more demanding, because the high γ and high K (reported K values
include Ktap water = 300 µS/cm, Kdeionized water = 3.3 µS/cm, Kdistilled water = 1.1 µS/cm)
can easily trigger a Corona discharge [71,82,111,146,183,186,190,191]. Due to
these and other properties of water, such as its high polarity and abundance of
dissociated ions (Chapter 2.1.4.4), the sign of the electrospraying potential U
significantly affects the obtainable electrospraying modes and their respective
stable voltage regimes. The CJM is obtainable for water at positive polarity, but
the voltage regime tends to be narrow [51,82,111,190,192]. A colloidal
suspension can be electrosprayable, if its medium consists of an
electrosprayable liquid [9,12,193].
Density ρ is not an important limiting factor to CJM electrosprayability on
its own at atmospheric pressure – superfluid liquid helium (ρ = 0.147 g/cm3 at
T = 2.2 K) and liquid metals (e.g. Au, ρ = 19.3 g/cm3) alike are applicable for the
technique [10,92,110,194,195]. Similarly, liquids of relative permittivity in the
range of at least 1.9 ≤ εr ≤ 182 have been found to be electrosprayable in CJM
[74,107,191]. Therefore, for the majority of liquids, εr does not single-handedly
constitute an obstacle to electrosprayability.
In suitable conditions, a jet of a considerably high η liquid protruding from
the Taylor cone does not disintegrate into droplets, i.e. the Taylor cone no
longer produces an electrospray. A sufficiently high η can be obtained for
example by dissolving a long-chained polymer in a high concentration to the
liquid. Electrospinning technique exploits this phenomenon to produce
extremely thin (5–1000 nm thickness) polymer threads and fibers, in contrast
to the ultrafine droplets and particles produced by the closely related technique
of electrospraying [73,178,196–206].
2.2.4.2. Droplet Size and Atomization Current
As discussed in Chapter 2.2.2.2, the main droplets electrosprayed in CJM are
very monodisperse, but never absolutely so. In addition, the main droplets are
accompanied by satellite droplets. Therefore, the electrosprayed droplet size
distribution cannot be described by a delta distribution. The droplet volume
median diameter dmed is, however, a good measure of the most probable size of
droplets electrosprayed in CJM [71]. For clarity, in this work the meaning of
droplet size d in the context of CJM electrospraying is taken to be dmed.
Consequently, these quantities will be used interchangeably where no danger of
confusion exists.
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suspension can be electrosprayable, if its medium consists of an
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its own at atmospheric pressure – superfluid liquid helium (ρ = 0.147 g/cm3 at
T = 2.2 K) and liquid metals (e.g. Au, ρ = 19.3 g/cm3) alike are applicable for the
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In suitable conditions, a jet of a considerably high η liquid protruding from
the Taylor cone does not disintegrate into droplets, i.e. the Taylor cone no
longer produces an electrospray. A sufficiently high η can be obtained for
example by dissolving a long-chained polymer in a high concentration to the
liquid. Electrospinning technique exploits this phenomenon to produce
extremely thin (5–1000 nm thickness) polymer threads and fibers, in contrast
to the ultrafine droplets and particles produced by the closely related technique
of electrospraying [73,178,196–206].
2.2.4.2. Droplet Size and Atomization Current
As discussed in Chapter 2.2.2.2, the main droplets electrosprayed in CJM are
very monodisperse, but never absolutely so. In addition, the main droplets are
accompanied by satellite droplets. Therefore, the electrosprayed droplet size
distribution cannot be described by a delta distribution. The droplet volume
median diameter dmed is, however, a good measure of the most probable size of
droplets electrosprayed in CJM [71]. For clarity, in this work the meaning of
droplet size d in the context of CJM electrospraying is taken to be dmed.
Consequently, these quantities will be used interchangeably where no danger of
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Controlling the droplet size in CJM electrospraying is important, since
various types of applications rely on it. In CJM, a reasonable estimate of the
droplet size d can be acquired from an equation of the form





where α = α(εr) is unitless, and the values of the exponents vary by
electrospraying conditions and authors as: 0 ≤ ν ≤ 1/6; 1/6 ≤ ξ ≤ 1/3; and
1/3 ≤ χ ≤ 1/2 [9,74,118,145,207,208]. In Equation 11, on average the most
influential electrospraying parameters are the liquid flow rate Q and
conductivity Κ, followed by surface tension γ and density ρ. The droplet size d
also increases to an extent with the capillary inner diameter di and with liquid
viscosity η, despite these parameters being absent in Equation 11 [9,74]. Liquids
of high η require more energy to disperse into droplets, as compared to liquids
of low η. It follows that droplets of a higher η liquid are generated at a lower
frequency, which results in larger droplets [209]. The effect of |U| on droplet
size (and charge) within the CJM regime remains comparatively quite
insignificant, since the operational voltage regime of the stable CJM is relatively
narrow, especially for liquids of high Κ [71,74,112,136]. Jet emission in CJM is
primarily dependent on the liquid properties – the electrospraying geometry is
not relevant, as long as the required CJM threshold electric field strength is
achieved, and no Corona discharges are generated [80,208]. Gañán-Calvo et. al.
have solved the scaling laws for d and atomization current I in four different
electrospraying liquid parameter subspaces, some of which are introduced and
discussed here as examples [74,208]. The electrospraying scaling laws have been
found in separate research papers to be accurate for at least liquids of εr < 31.2
[184]; and to approach experimental results at high (80 < εr ≤ 180) permittivity
(cf. water, εr = 80.2 at T = 20°C [175,190]) [191].
If the liquid is of sufficiently high η and high Κ, so that the condition
δη(Q/Q0)−1/3 << 1 is true (cf. Equations 6 and 9), it follows that the liquid axial
momentum transmits efficiently throughout the liquid for a flat axial velocity
profile, and that the electric current flows in the bulk of the cone [74]. This
leads to a I ~ Q1/2 scaling law of the atomization current:
� ��⁄  ~ �� ��(�� − 1)� �⁄⁄ �
� �⁄
. (12)
The I ~ Q1/2 scaling law has been obtained by other authors as well, and is
applicable for many common solvents such as ethanol, acetone, and (NaI-
29
doped) glycerol [74,130,144,145,207,210]. According to experimental results,
this scaling law is fairly accurate even for δη(Q/Q0)−1/3 ≈ 1 [74]. For a liquid that
obeys the I ~ Q1/2 scaling law (Equation 12), the dimensionless droplet (jet) size
is proportional to
� ��⁄  ~ �(�� − 1)� �⁄ � ��⁄ �
� �⁄
. (13)
Equations 6, 8, and 13 yield the exponents in Equation 11 as ν = 0, and
ξ = χ = 1/3:






It is notable in the previous result that the charge per unit mass obeys the
proportionality of the Rayleigh limit, I/Q ~ d−3/2, as shown equivalently in
Equation 5. This assumption has been shown to be valid approximation and is
frequently made in CJM electrospraying [71,74,118,133,140]. The same
proportionality is valid for liquids of low η and low Κ, i.e. liquids that fulfill the
condition δη(Q/Q0)−1/3 >> 1. The motion of such a liquid is inviscid, an axial
distance significantly longer than L0 is required for the liquid to become
thoroughly accelerated. Consequently, the liquid velocity is much greater at the
jet surface as compared to the bulk, and the current I consists nearly exclusively
of surface charge convection [74]. For best agreement with experimental data
for liquids of low η and low Κ, Gañán-Calvo et. al. have concluded that the total
electrospraying current I ~ dj1/2, where dj is the jet diameter [74]. Moreover, a
common approximation for liquids of low η is that d = 1.89 × dj, as for
uncharged jets [71,74]. These assumptions yield the I ~ Q1/4 scaling law for
liquids of low η and low Κ [74]:
� ��⁄  ~ (� ��⁄ )� �⁄ . (15)
Consequently, the dimensionless droplet (jet) size for liquids that obey the
I ~ Q1/4 scaling law (Equation 15) is obtained from [74]:
� ��⁄ =  ��(� ��⁄ )� �⁄ , (16)
where kd is a proportionality constant, to be measured experimentally.
Equations 6, 8, and 16 yield the exponents in Equation 11 as ν = ξ = 1/6, and
χ = 1/2:
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To obtain intermediate scaling laws, Gañán-Calvo et. al. incorporated a
dependence of Q on the liquid velocity at the surface of the jet vs (of the form
vs ~ Qβ, where 0 ≤ β ≤ 1/9) to the scaling laws derived for liquids of low η and
low Κ (Equations 15–17),. For β = 1/9, they obtained the I ~ Q1/3 scaling law,
yielding d ~ Q4/9 (χ = 4/9 in Equation 11) with the assumption of droplet charge
proportionality to the Rayleigh limit (q ~ I/Q ~ d−3/2) [74].
More recently, Gañán-Calvo et. al. have specified that as the Taylor cone
surface charge has been shown to be in equilibrium, then (similarly to the low η
and low Κ case described previously) the bulk liquid can be considered quasi-
neutral for all liquids of large enough electrical mobility, except for the most
conductive liquids such as tap water or liquid metals. This is because for
sufficiently conductive liquids, a charge double-layer forms to the liquid
surface, and its thickness is small in comparison to d0 except for liquids of very
high Κ [184]. In addition, for most liquids, the liquid velocity profile is
reasonably flat to justify the use of a one-dimensional model of the slender jet.
Liquid motion in the bulk of the meniscus can be considered irrelevant to the
electrospraying mechanism, except for marginally few liquids of very low η and
Κ [184]. In practice, axial momentum has been observed to diffuse rapidly from
the liquid surface to the bulk in small jets, even for liquids of very low η, such as
hexane or heptane [80,211]. Charge convection can be considered the
dominant charge transfer mechanism for these solvents as well, as they conduct
poorly [74,181]. A significantly simplified cone-jet model, where Fε is found
negligible, can be applied for liquids that fall in between these extreme cases.
The model yields an effectively universal scaling law of I ~ Q1/2, independent of
εr:
� ��⁄ = � ��(� ��⁄ )� �⁄ , (18)
where kI is a proportionality constant that depends on the electrospraying
geometry, to be measured experimentally. The scaling law was confirmed
experimentally using various liquids of εr ≤ 80.2 (water), with kI = 2.6 measured
for the authors’ experimental setup [184]. The droplet size scaling law d ~ Q1/2
was obtained equivalently to Equations 16 and 17, and confirmed with kd = 2.9
as measured by the authors [184]. In this model, the droplet charge scales as
q ~ d−1.
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The droplet size scaling law d ~ Q1/2 of Equations 16 and 17 was also
obtained by Hartman et. al. for varicose jet break-up regime using experiments
and a different derivation, in which a flat liquid velocity profile and thus the
I ~ Q1/2 scaling law (similar to Equation 18) was assumed [118]. The authors
observed in their experiments that as the jet entered the kink (whipping) break-
up regime, d scaling transitioned to the d ~ Q1/3 dependence, similar to
Equations 13 and 14. This scaling law transition was explained by the authors
as the droplet charge beginning to scale as a fixed fraction of the Rayleigh limit
charge (Equation 4) in the whipping break-up regime, unlike in the varicose
break-up regime [118].
In the inertia-electrostatic force regime (Q > Q0/δη, εrδη < 1), where charge
convection was assumed to be the dominant charge transfer mechanism,
scaling laws I ~ Q1/2 (Equation 18) and d ~ Q1/2 (Equations 16 and 17) were
obtained for L0 ≤ di, e.g. excluding nano-electrosprays [80,208]. In the
derivation, volume specific force balance was considered between only the
dominant driving and resistant forces – the electrostatic force Fes and inertia FI,
respectively. The authors note, however, that the electric tangential force Fet is
also a significant driving force, acting along the length of the jet [80]. Also,
viscous forces Fη are may not be neglectible for all liquids, even before entering
the electrospinning regime [9,74].
2.2.5. Droplet Evaporation and Coulomb Fission
After being ejected from the liquid meniscus, electrosprayed droplets are
rapidly accelerated in the external electric field E. The velocity vi of droplet i














������ − ����, (19)
where CD is the droplet drag coefficient in the surrounding gas, ρg and ρd are the
respective densities of the surrounding gas and the droplet, di and qi are the
droplet diameter and charge, ri is the vector position of charge qi, rij is the vector
distance between charges qi and qj (cf. Equation 1), and g is acceleration due to
gravity [141,142]. On the right hand side of Equation 19, the first term is the
resistive drag force of the surrounding gas, and the second term is the
Coulombic force exerted by the external electric field E. The third term
includes mutual Coulombic forces between the droplets and image charges
induced by the droplets (image force). The last term, consisting of gravity force
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To obtain intermediate scaling laws, Gañán-Calvo et. al. incorporated a
dependence of Q on the liquid velocity at the surface of the jet vs (of the form
vs ~ Qβ, where 0 ≤ β ≤ 1/9) to the scaling laws derived for liquids of low η and
low Κ (Equations 15–17),. For β = 1/9, they obtained the I ~ Q1/3 scaling law,
yielding d ~ Q4/9 (χ = 4/9 in Equation 11) with the assumption of droplet charge
proportionality to the Rayleigh limit (q ~ I/Q ~ d−3/2) [74].
More recently, Gañán-Calvo et. al. have specified that as the Taylor cone
surface charge has been shown to be in equilibrium, then (similarly to the low η
and low Κ case described previously) the bulk liquid can be considered quasi-
neutral for all liquids of large enough electrical mobility, except for the most
conductive liquids such as tap water or liquid metals. This is because for
sufficiently conductive liquids, a charge double-layer forms to the liquid
surface, and its thickness is small in comparison to d0 except for liquids of very
high Κ [184]. In addition, for most liquids, the liquid velocity profile is
reasonably flat to justify the use of a one-dimensional model of the slender jet.
Liquid motion in the bulk of the meniscus can be considered irrelevant to the
electrospraying mechanism, except for marginally few liquids of very low η and
Κ [184]. In practice, axial momentum has been observed to diffuse rapidly from
the liquid surface to the bulk in small jets, even for liquids of very low η, such as
hexane or heptane [80,211]. Charge convection can be considered the
dominant charge transfer mechanism for these solvents as well, as they conduct
poorly [74,181]. A significantly simplified cone-jet model, where Fε is found
negligible, can be applied for liquids that fall in between these extreme cases.
The model yields an effectively universal scaling law of I ~ Q1/2, independent of
εr:
� ��⁄ = � ��(� ��⁄ )� �⁄ , (18)
where kI is a proportionality constant that depends on the electrospraying
geometry, to be measured experimentally. The scaling law was confirmed
experimentally using various liquids of εr ≤ 80.2 (water), with kI = 2.6 measured
for the authors’ experimental setup [184]. The droplet size scaling law d ~ Q1/2
was obtained equivalently to Equations 16 and 17, and confirmed with kd = 2.9
as measured by the authors [184]. In this model, the droplet charge scales as
q ~ d−1.
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The droplet size scaling law d ~ Q1/2 of Equations 16 and 17 was also
obtained by Hartman et. al. for varicose jet break-up regime using experiments
and a different derivation, in which a flat liquid velocity profile and thus the
I ~ Q1/2 scaling law (similar to Equation 18) was assumed [118]. The authors
observed in their experiments that as the jet entered the kink (whipping) break-
up regime, d scaling transitioned to the d ~ Q1/3 dependence, similar to
Equations 13 and 14. This scaling law transition was explained by the authors
as the droplet charge beginning to scale as a fixed fraction of the Rayleigh limit
charge (Equation 4) in the whipping break-up regime, unlike in the varicose
break-up regime [118].
In the inertia-electrostatic force regime (Q > Q0/δη, εrδη < 1), where charge
convection was assumed to be the dominant charge transfer mechanism,
scaling laws I ~ Q1/2 (Equation 18) and d ~ Q1/2 (Equations 16 and 17) were
obtained for L0 ≤ di, e.g. excluding nano-electrosprays [80,208]. In the
derivation, volume specific force balance was considered between only the
dominant driving and resistant forces – the electrostatic force Fes and inertia FI,
respectively. The authors note, however, that the electric tangential force Fet is
also a significant driving force, acting along the length of the jet [80]. Also,
viscous forces Fη are may not be neglectible for all liquids, even before entering
the electrospinning regime [9,74].
2.2.5. Droplet Evaporation and Coulomb Fission
After being ejected from the liquid meniscus, electrosprayed droplets are
rapidly accelerated in the external electric field E. The velocity vi of droplet i
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where CD is the droplet drag coefficient in the surrounding gas, ρg and ρd are the
respective densities of the surrounding gas and the droplet, di and qi are the
droplet diameter and charge, ri is the vector position of charge qi, rij is the vector
distance between charges qi and qj (cf. Equation 1), and g is acceleration due to
gravity [141,142]. On the right hand side of Equation 19, the first term is the
resistive drag force of the surrounding gas, and the second term is the
Coulombic force exerted by the external electric field E. The third term
includes mutual Coulombic forces between the droplets and image charges
induced by the droplets (image force). The last term, consisting of gravity force
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and buoyancy, is neglectable for conventional CJM electrospraying conditions,
due to the high charge-to-mass ratio of the droplets [62,141,142]. The droplet
velocity vi asymptotically approaches the dynamically changing terminal
velocity vt,i, obtainable from Equation 19 for the condition �̇� = 0.
For water droplets of 10–100 µm in size, terminal velocity in the absence of
electrical forces is of the order of 3–300 mm/s, and is reached (to a degree of
95%) in about 1–100 ms [62,212]. Thus, uncharged water droplets of such small
size adjust their velocity to that of the surrounding gas flow almost
instantaneously. However, under the brief influence of the extracting electric
field, charged droplets electrosprayed in CJM can be observed to reach initial
velocities of tens of m/s, as measured a few millimeters away from the Taylor
cone [130,213]. The droplets decelerate as the distance from the Taylor cone
increases, and |E| decreases. The induced image field once again accelerates the
charged droplets (or residual particles) as they approach the collection
electrode [142,214]. The time required for electrosprayed droplet i to migrate
from the meniscus to the surface of the collector electrode (droplet air-time)
can be expressed as �� = ∫�� ∙ ��� , where the droplet trajectory length
�� = ∫���  depends primarily on the electrospraying geometry.
For droplets composed of a volatile liquid, such as many of the common
organic solvents, liquid evaporation takes place during the droplet air-time. In
the evaporation process, neutral molecules cross the liquid-gas interface and
escape the droplet. Therefore, evaporation does not affect droplet charge, as
have been shown experimentally [62,173]. However, the charge to mass ratio
qi/mi of an evaporating and charged droplet is increased due to its diminishing
size. Thus, the droplet eventually reaches the Rayleigh limit charge (Equation 5)
and consequently, as discussed in Chapter 2.2.3, becomes unstable. In a state of
such instability, the droplet ejects portions of its mass and charge in events of
Coulomb fission, or Coulombic explosions [86,121,140,172,207,215]. Droplets
charged nearly to the Rayleigh limit have been in most cases observed to emit
jets of extremely fine satellite droplets (d < 100 nm) which are highly charged
[62,121–123,140,172,207,215]. In this fine Coulomb fission, a transient Taylor
cone or liquid meniscus of similar characteristics forms in the surface of the
parent droplet [71,140,207]. The ejected satellite droplets significantly deplete
the parent droplet of its charge, while carrying away little of its mass [121–
123,207]. It is considered possible that a part of the charge expelled in fine
Coulomb fission could in certain cases be carried by ions ejected from the
droplet by field emission [207]. For liquids that cannot form a Taylor cone, e.g.
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liquids of very low Κ, a rough Coulomb fission has been observed in some
scenarios. In rough fission, the droplet splits into two or several relatively large
and stable fragments [173,207]. The fission mode is determined by the droplet
size and liquid properties in a way which is not completely understood,
although it is possible that analogy to the underlying atomization modes exist
to an extent [207].
In CJM electrospraying, ordinarily used electrospraying inter-electrode
distances (of the order of 1 m) generally provide sufficient droplet air-time to
allow for appreciable evaporation during the droplet transport [62,142]. The
evaporation rate is based on liquid selection, and can be further enhanced or
controlled to an extent by varying the electrosprayed droplet size d; the liquid
flow rate Q, which in part affects the equilibrium partial pressure of the liquid
due to evaporation near the electrosprayed droplet jets; the temperature of the
electrosprayed liquid; as well as the composition, flow, temperature, and total
pressure of the surrounding gas [113,142,216]. With a solute material or
dispersed (nano)particles present in droplets of a volatile electrosprayed liquid,
evaporation of the liquid from the droplet will leave behind either residual ions
[66], or residual solid (agglomerate) particles. The phenomenon is exploited in
micro- and nanoparticle production by electrospraying [10,83,195]. Provided
that the liquid evaporation is completed before deposition, and that the
evaporation rate is moderate so as to not disrupt the formation of residual
particles, the solvent evaporation rate does not significantly affect the final size
or shape of the deposited residual particles (relics). The size of deposited
residual particles then depends primarily on the concentration of the
nonvolatile solute and/or dispersed components in the electrosprayed liquid;
and the size and charge of the electrosprayed droplets [214,217,218]. Residual
particles that form during the transport become spherical [214]. However, at
very fast evaporation rates, porosity can be induced to the particles [113].
Accordingly, the corresponding electrospraying parameters are used to control
the properties of micro- and nanosized thin films and particle powders
produced by electrospraying [9,10,142,162,214].
2.2.6. Droplet Neutralization
The induced droplet charge can affect the collection or deposition efficiency of
droplets or residual particles positively or negatively, depending on the
electrospraying arrangement. For example, droplet or particle charge can be
31004982_Turun_yliopisto_Vaitoskirja_Jorma_Roine_Luonn_tiet_ja_tekn_tdk_sisus_19_01_22.indd   48 22.1.2019   8.08.05
32
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velocity vt,i, obtainable from Equation 19 for the condition �̇� = 0.
For water droplets of 10–100 µm in size, terminal velocity in the absence of
electrical forces is of the order of 3–300 mm/s, and is reached (to a degree of
95%) in about 1–100 ms [62,212]. Thus, uncharged water droplets of such small
size adjust their velocity to that of the surrounding gas flow almost
instantaneously. However, under the brief influence of the extracting electric
field, charged droplets electrosprayed in CJM can be observed to reach initial
velocities of tens of m/s, as measured a few millimeters away from the Taylor
cone [130,213]. The droplets decelerate as the distance from the Taylor cone
increases, and |E| decreases. The induced image field once again accelerates the
charged droplets (or residual particles) as they approach the collection
electrode [142,214]. The time required for electrosprayed droplet i to migrate
from the meniscus to the surface of the collector electrode (droplet air-time)
can be expressed as �� = ∫�� ∙ ��� , where the droplet trajectory length
�� = ∫���  depends primarily on the electrospraying geometry.
For droplets composed of a volatile liquid, such as many of the common
organic solvents, liquid evaporation takes place during the droplet air-time. In
the evaporation process, neutral molecules cross the liquid-gas interface and
escape the droplet. Therefore, evaporation does not affect droplet charge, as
have been shown experimentally [62,173]. However, the charge to mass ratio
qi/mi of an evaporating and charged droplet is increased due to its diminishing
size. Thus, the droplet eventually reaches the Rayleigh limit charge (Equation 5)
and consequently, as discussed in Chapter 2.2.3, becomes unstable. In a state of
such instability, the droplet ejects portions of its mass and charge in events of
Coulomb fission, or Coulombic explosions [86,121,140,172,207,215]. Droplets
charged nearly to the Rayleigh limit have been in most cases observed to emit
jets of extremely fine satellite droplets (d < 100 nm) which are highly charged
[62,121–123,140,172,207,215]. In this fine Coulomb fission, a transient Taylor
cone or liquid meniscus of similar characteristics forms in the surface of the
parent droplet [71,140,207]. The ejected satellite droplets significantly deplete
the parent droplet of its charge, while carrying away little of its mass [121–
123,207]. It is considered possible that a part of the charge expelled in fine
Coulomb fission could in certain cases be carried by ions ejected from the
droplet by field emission [207]. For liquids that cannot form a Taylor cone, e.g.
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liquids of very low Κ, a rough Coulomb fission has been observed in some
scenarios. In rough fission, the droplet splits into two or several relatively large
and stable fragments [173,207]. The fission mode is determined by the droplet
size and liquid properties in a way which is not completely understood,
although it is possible that analogy to the underlying atomization modes exist
to an extent [207].
In CJM electrospraying, ordinarily used electrospraying inter-electrode
distances (of the order of 1 m) generally provide sufficient droplet air-time to
allow for appreciable evaporation during the droplet transport [62,142]. The
evaporation rate is based on liquid selection, and can be further enhanced or
controlled to an extent by varying the electrosprayed droplet size d; the liquid
flow rate Q, which in part affects the equilibrium partial pressure of the liquid
due to evaporation near the electrosprayed droplet jets; the temperature of the
electrosprayed liquid; as well as the composition, flow, temperature, and total
pressure of the surrounding gas [113,142,216]. With a solute material or
dispersed (nano)particles present in droplets of a volatile electrosprayed liquid,
evaporation of the liquid from the droplet will leave behind either residual ions
[66], or residual solid (agglomerate) particles. The phenomenon is exploited in
micro- and nanoparticle production by electrospraying [10,83,195]. Provided
that the liquid evaporation is completed before deposition, and that the
evaporation rate is moderate so as to not disrupt the formation of residual
particles, the solvent evaporation rate does not significantly affect the final size
or shape of the deposited residual particles (relics). The size of deposited
residual particles then depends primarily on the concentration of the
nonvolatile solute and/or dispersed components in the electrosprayed liquid;
and the size and charge of the electrosprayed droplets [214,217,218]. Residual
particles that form during the transport become spherical [214]. However, at
very fast evaporation rates, porosity can be induced to the particles [113].
Accordingly, the corresponding electrospraying parameters are used to control
the properties of micro- and nanosized thin films and particle powders
produced by electrospraying [9,10,142,162,214].
2.2.6. Droplet Neutralization
The induced droplet charge can affect the collection or deposition efficiency of
droplets or residual particles positively or negatively, depending on the
electrospraying arrangement. For example, droplet or particle charge can be
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beneficial for steering their flow in targeted deposition techniques [158,159]. In
dry powder production, droplets are often electrically neutralized immediately
after being ejected from extraction electric field [113,136,219]. The benefits of
such in situ neutralization include, most importantly, elimination of Coulomb
fission, which is necessary to achieve a consistent residual particle size
[10,113,136]. Moreover, neutralization eliminates external Coulombic forces
and mutual Coulombic repulsion acting on the droplets and particles. In some
setups, this could improve the particle collection efficiency, as well as reduce
agglomeration of the deposited particles that could occur due to local surface
charge domains in an insulating collection dish or substrate, such as a Petri dish
or a nylon filter [13,219–221].
The different neutralization methods utilized in electrostatic atomization
include Corona ion source neutralizers (cf. Chapter 2.1.4.3)
[10,113,138,186,219,222]; radioactive sources such as Po210, Am241, or Cm242 for
neutralization of small droplets [136,191,223]; X-ray photoionization for
neutralization of residual particles [221,224]; or operation of two electrosprays
of opposite polarities, with the oppositely charged droplets attracting each
other, merging and mutually neutralizing by charge transfer (cf.
Chapter 2.3.2.1) [9,225]. The rate of spontaneous aerial discharge
(Chapter 2.1.4.4) is generally too low to result in any significant neutralization
of a droplet electrosprayed in CJM, with a typical droplet size of 10 nm to
100 µm and air-time of the order of 0.1–100 s.
2.3. Electroencapsulation
A material which is either vulnerable to the surrounding environment, affects
its surroundings adversely, or is in a metastable or difficult to handle physical
state or form, can be physically confined and chemically isolated from its
surroundings by encapsulating it in an envelope or matrix composed of shell
material  [7,226–231]. Encapsulation can render the payload (core material)
mechanically easier to process and chemically inert [7,9]. For example,
successfully encapsulating droplets of a liquid dispersion of nanoparticles in
solid shell capsules of diameter D ≥ 10 µm effectively increases the size scale of
the handled objects by orders of magnitudes. For purposes of handling, storing,
processing, and dosing, the encapsulated payload could then be processed as a
dry powder, with the surface properties of the shell material [9,232,233]. An
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encapsulated solid may assume a disordered, metastable physical state
(cf. Chapter 2.4.1) – for example in the form of a molecular, amorphous, or
nanocrystalline solid solution or dispersion [7,234,235]. In the spatial
confinement of a solid dispersion, the diffusion mobility of the core material
molecules is remarkably diminished or suppressed. Consequently, precipitation
and crystal growth are subdued or inhibited. Therefore, by encapsulation of the
core material into a solid dispersion, its disordered physical state can be
stabilized to endure even stressful external conditions over extended periods of
time [7,235]. The core material release kinetics and trigger conditions (melting,
rupture or dissolution of the shell material, diffusion) are controllable by
adjustments of capsule properties such as its size, composition, and structure
[7,226,229,230].
Electroencapsulation is a process of encapsulation assisted by electrical
forces, i.e. by use of electrospraying in CJM [9,236]. Other modes of
electrospraying, such as the dripping mode, can be used for
electroencapsulation as well, but will not be discussed in this work [128].
2.3.1. Material prerequisites
In electroencapsulation, the core material can be solid, liquid or gaseous. Solid
or gaseous payload materials must be dissolved or dispersed to a liquid or
colloid formulation, prior to electrospraying. The shell material, in order to
form either the capsule envelope or the matrix, and to be electrosprayable in
CJM, consists of a liquid or a solid dissolved in a liquid phase
[9,12,232,236,237].
The core and shell materials can be introduced to a common electrospraying
liquid, or they can be formulated into separate core and shell electrospraying
liquids. In correspondence, electroencapsulation can be used for fabrication of
two types of micro- and nanocomposite materials: micro- or nanomatrix
particles consisting of a payload (core) material as a uniformly distributed solid
solution or solid dispersion in a suitable solid matrix (shell) material; and core-
shell micro- or nanocapsules with a solid, liquid or gaseous core enveloped in a
solid (or liquid) shell layer; [9,12,232,236,238–240].
In order for droplets of two species of liquids to successfully form core-shell
capsules, the core and shell liquids must be immiscible and mutually wettable.
The droplet of higher surface tension liquid is then enveloped by the droplet of
lower surface tension liquid upon bringing the two into contact: γc > γs [232].
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100 µm and air-time of the order of 0.1–100 s.
2.3. Electroencapsulation
A material which is either vulnerable to the surrounding environment, affects
its surroundings adversely, or is in a metastable or difficult to handle physical
state or form, can be physically confined and chemically isolated from its
surroundings by encapsulating it in an envelope or matrix composed of shell
material  [7,226–231]. Encapsulation can render the payload (core material)
mechanically easier to process and chemically inert [7,9]. For example,
successfully encapsulating droplets of a liquid dispersion of nanoparticles in
solid shell capsules of diameter D ≥ 10 µm effectively increases the size scale of
the handled objects by orders of magnitudes. For purposes of handling, storing,
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and crystal growth are subdued or inhibited. Therefore, by encapsulation of the
core material into a solid dispersion, its disordered physical state can be
stabilized to endure even stressful external conditions over extended periods of
time [7,235]. The core material release kinetics and trigger conditions (melting,
rupture or dissolution of the shell material, diffusion) are controllable by
adjustments of capsule properties such as its size, composition, and structure
[7,226,229,230].
Electroencapsulation is a process of encapsulation assisted by electrical
forces, i.e. by use of electrospraying in CJM [9,236]. Other modes of
electrospraying, such as the dripping mode, can be used for
electroencapsulation as well, but will not be discussed in this work [128].
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In electroencapsulation, the core material can be solid, liquid or gaseous. Solid
or gaseous payload materials must be dissolved or dispersed to a liquid or
colloid formulation, prior to electrospraying. The shell material, in order to
form either the capsule envelope or the matrix, and to be electrosprayable in
CJM, consists of a liquid or a solid dissolved in a liquid phase
[9,12,232,236,237].
The core and shell materials can be introduced to a common electrospraying
liquid, or they can be formulated into separate core and shell electrospraying
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The envelopment can be complete if the capsule does not contact another solid
or liquid surface (except for possible gelatinizing or polymerizing baths), and if
an adequate volume of shell liquid is present to cover the whole surface of the
core droplet. The capsule shell can finally be solidified, either by cooling and
subsequent phase transition of the shell material [227]; by chemical reactions
such as gelatinization, or polymerization [9,236,239,241]; or, with a suitable
polymer dissolved to the shell material, by evaporation of excess solvent
[9,236,242].
In general, the highest usable concentrations of any dispersed or dissolved
solids can be a limiting factor to the process yield. Excessively high
concentrations of dispersed solid materials may promote agglomeration of the
dispersed particles in the electrospraying liquid, while solute concentrations
approaching the solubility limit in the electrospraying liquid could result in a
premature solidification or crystallization of the solute at the electrospraying
needle tip. Consequently, the electrospray CJM operation may become instable
or intermittent, which eventually risks clogging the electrospraying nozzle
[9,113,119,240]. Miscible or dispersed liquid components can be added to the
formulations as needed. However, any liquid formulations or their co-extruded
combinations to be electrostatically atomized during the electroencapsulation
process must meet the requirements for electrospraying in CJM, discussed in
Chapter 2.2.4.1 for single-phase liquids.
2.3.2. Electroencapsulation methods
To support extensive use of electroencapsulation in the production of
nanostructured solid solution matrix particles as well as micro- and
nanocapsules for a diversity of applications, several electroencapsulation
methods have been studied [9,12,128,232,236,242]. Different material
combinations and liquid formulations allow for experimenting with the
creation of versatile micro- and nanocomposite matrix or capsule structures.
The range of capsule sizes producible by electrospraying is wide, and capsules
as small as 150 nm can be obtained, while retaining a narrow size distribution
[240,243]. The electrospraying configurations of some relevant
electroencapsulation methods, which utilize either a single electrospraying
nozzle or a pair of parallel or coaxial electrospraying nozzles operated in CJM,
are depicted schematically in Figures 5a–c and will be briefly discussed in the
chapters to follow.
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Figure 5. Schematically shown electrospraying configurations for electroencapsulation
by the use of a) a single nozzle, b) parallel nozzles, and c) coaxial nozzles operated in
CJM. In b), the extractor electrodes are visible.
By selection of the electrospraying configuration and adjustment of the
electrospraying parameters (Chapter 2.2.2), a feasible encapsulation efficiency
can potentially be achieved together with suitable payload release trigger
conditions and release profiles from the produced micro- and nanostructured
materials for various applications, while maintaining capsule integrity, stability,
and functionality in the desired conditions [153,154,232,237,238,240,243–245].
These properties can be beneficial for instance in food processing, cosmetic
industry, and textile industry applications for the addition, protection and
controlled release of coloring or active ingredients (e.g. flavors, dyes, enzymes,
vitamins, or fragrances) [9,227,236,245–247]; in pharmaceutical applications
such as targeted delivery and controlled release of drugs, living cells, viruses, or
genetic material [128,153,154,219,233,237,240,242,248]; or in controlling the
efficiency of insecticide targeting [9,249].
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Figure 5. Schematically shown electrospraying configurations for electroencapsulation
by the use of a) a single nozzle, b) parallel nozzles, and c) coaxial nozzles operated in
CJM. In b), the extractor electrodes are visible.
By selection of the electrospraying configuration and adjustment of the
electrospraying parameters (Chapter 2.2.2), a feasible encapsulation efficiency
can potentially be achieved together with suitable payload release trigger
conditions and release profiles from the produced micro- and nanostructured
materials for various applications, while maintaining capsule integrity, stability,
and functionality in the desired conditions [153,154,232,237,238,240,243–245].
These properties can be beneficial for instance in food processing, cosmetic
industry, and textile industry applications for the addition, protection and
controlled release of coloring or active ingredients (e.g. flavors, dyes, enzymes,
vitamins, or fragrances) [9,227,236,245–247]; in pharmaceutical applications
such as targeted delivery and controlled release of drugs, living cells, viruses, or
genetic material [128,153,154,219,233,237,240,242,248]; or in controlling the
efficiency of insecticide targeting [9,249].
31004982_Turun_yliopisto_Vaitoskirja_Jorma_Roine_Luonn_tiet_ja_tekn_tdk_sisus_19_01_22.indd   53 22.1.2019   8.08.07
38
2.3.2.1. Single Nozzle
Electrospraying of a colloidal suspension from a single nozzle in CJM (as
shown in Figure 5a), and subsequent solidification (cf. Chapter 2.3.1) of the
continuous phase (shell liquid) is a relatively uncomplicated
electroencapsulation method that can be carried out using the simple
electrospraying setup of Figure 2 [219,241,250]. The dispersed phase
(suspended payload particles) can be solid, liquid or gaseous. With a
sufficiently low concentration of the dispersed material, micro- or nanosized
solid capsules carrying a single particle, droplet, or bubble can be produced [9].
Capsules or matrix particles containing multiple dispersed payload particles
can be produced by increasing the payload concentration or droplet size.
Similarly, a solute payload material can be electroencapsulated using a single
electrospraying nozzle. In such a scenario, the shell material is dissolved along
with the payload material in the electrospraying liquid [153,240,244,251,252].
The electrospraying of such a single-phase liquid is comparable in complexity
to the electrospraying of a pure solvent (Figure 3d). During the solidification
process of the resulting matrix particles, the physical state of the payload
material is determined [94,253]. It is possible for the payload material to
remain molecular, constituting a solid solution in the matrix [7,94,252]. The
payload can also form dispersed nanocrystals or amorphous clusters during the
solidification, resulting in a solid dispersion (cf. Chapter 2.4.3) [7,94,240,254–
256].
Using a single nozzle, the core liquid can be electrosprayed into a
gelatinizing shell liquid bath, where the shell layer forms around the core
droplets to complete a core-shell structure (cf. Chapter 2.3.1) [257].
Capsules or matrix particles produced using the single nozzle method carry
a charge of the same polarity as the electrospraying nozzle. Thus, capsule
neutralization (cf. Chapter 2.2.6) or the use of an oppositely charged collection
electrode is required for best collection efficiency.
2.3.2.2. Bi-Polar Parallel Nozzles
In Figure 5b, the electroencapsulation principle using a pair of parallel nozzles
kept in high potentials of opposite polarities is shown. For core-shell capsule
production, the immiscible core and shell liquids are electrosprayed separately
from the nozzles of opposite polarities, and as a result the core and shell
droplets are charged oppositely. Ejected to a shared chamber free of significant
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external electric fields (Chapter 3.2.1), the core and shell droplets are attracted
to one another by Coulombic forces, proportional to r−2, where r is the inter-
particle distance (Equation 1). At a sufficiently close distance, image charge on
the opposing particle lead to an additional attracting force, proportional to r−5
[232]. Upon contact, the droplets form a capsule due to the difference in
surface tension (as described in Chapter 2.3.1), and neutralize each other
partially or completely by charge transfer [9,12,232,236]. Any net charge qcaps
left in the capsules continue to attract droplets of the oppositely charged
species. Next, the shell layer of the capsules is solidified if necessary, and the
capsules are steered to a collection surface or dish by means of gravity, air flow,
or electromagnetic forces. The sequence of solidification and collection
depends on the respective methods (Chapter 2.3.1) used. Both the shell and
core electrospraying liquids can consist of a single phase or a colloidal
suspension. The structure of the produced capsules is determined most
importantly by the droplet size and charge distributions, the non-volatile
material concentrations in the electrospraying liquids, evaporation rates of
volatile liquids, and the external electric field in the encapsulation space.
In CJM electrospraying, the main droplet size distribution is narrow
(Chapter 2.2.2.2), and droplet charge is proportional to droplet size
(Chapter 2.2.5). Ideally, if at any time interval the induced charge in the
electrosprayed droplets available for encapsulation was of a similar proportion
of the total electrosprayed charge for both of the parallel nozzles, the mean
residual capsule charge ����������� could be deduced qualitatively based on the
measurable nozzle atomization currents Ic and Is. In the case of current
imbalance (|Ic| ≠ |Is|), the mean residual capsule charge ����������� ≠ 0 would lean
towards the sign of the stronger atomization current in magnitude. An
improved process yield could then be gained by neutralization of the formed
capsules, or by adjusting the polarity of the collection electrode accordingly to
be of the opposite sign as �����������. With balanced currents (|Ic| ~ |Is|), ����������� ~ 0.
In this scenario, selective collection of negatively charged, neutral, or positively
charged capsules could possibly be exploited at the expense of process yield to
potentially gain a higher capsule structural uniformity (by size) among the
collected, charge filtered capsules, as compared to the whole of the
electrosprayed sample. However, as discussed in Chapter 2.2.2.2, the
contribution of satellite droplet charge could affect the encapsulation process
significantly. In practice, optimization and verification of the parallel nozzle
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[232]. Upon contact, the droplets form a capsule due to the difference in
surface tension (as described in Chapter 2.3.1), and neutralize each other
partially or completely by charge transfer [9,12,232,236]. Any net charge qcaps
left in the capsules continue to attract droplets of the oppositely charged
species. Next, the shell layer of the capsules is solidified if necessary, and the
capsules are steered to a collection surface or dish by means of gravity, air flow,
or electromagnetic forces. The sequence of solidification and collection
depends on the respective methods (Chapter 2.3.1) used. Both the shell and
core electrospraying liquids can consist of a single phase or a colloidal
suspension. The structure of the produced capsules is determined most
importantly by the droplet size and charge distributions, the non-volatile
material concentrations in the electrospraying liquids, evaporation rates of
volatile liquids, and the external electric field in the encapsulation space.
In CJM electrospraying, the main droplet size distribution is narrow
(Chapter 2.2.2.2), and droplet charge is proportional to droplet size
(Chapter 2.2.5). Ideally, if at any time interval the induced charge in the
electrosprayed droplets available for encapsulation was of a similar proportion
of the total electrosprayed charge for both of the parallel nozzles, the mean
residual capsule charge ����������� could be deduced qualitatively based on the
measurable nozzle atomization currents Ic and Is. In the case of current
imbalance (|Ic| ≠ |Is|), the mean residual capsule charge ����������� ≠ 0 would lean
towards the sign of the stronger atomization current in magnitude. An
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electroencapsulation process is highly empirical in nature due to the wealth of
variables generally involved in it.
The process yield can be scaled up in principle by increasing the numbers of
core and shell liquid nozzles nc and ns in the parallel nozzle
electroencapsulation setup, although a bipolar array would be more complex
than a nozzle array comprised of a single polarity [9,89,91,93,95–102,236].
With roughly similar electrospraying parameters for each nozzle of the same
type of electrospray, the total atomization currents could be coarsely balanced
by weighing the numbers of operational nozzles according to ncIc = nsIs.
However, the voltages would generally need to be increased as nozzles of
opposite polarities are brought closer together, and in different parts of an
electrospraying array, the electrospraying parameters would need to be tweaked
due to differing geometry-dependent proximity effects [12,99]. As a result, the
electrospraying currents Ic and Is would likely vary by nozzle position in an
array [89,99,102]. Coarse current balancing by adjusting nc/ns could still be
applicable, if proportional variations of Ic and Is by position in the array can be
assumed to be similar, and if the array is sufficiently large that the proportion
of edge nozzles can be considered small.
The parallel nozzle configuration is feasible for the production of solid
nano- or micromatrix particles, with the payload (core) material loaded in the
particles as a solid solution or a solid dispersion [7,240,252,254–256]. As in the
single nozzle process (Chapter 2.3.2.1), the payload material is dissolved in the
electrospraying liquid together with the matrix (shell) material
[153,240,244,251]. In a basic arrangement, identical liquids are electrosprayed
from both nozzles, using identical electrospraying parameters (except for the
polarity). Thus, droplet yield can be doubled as compared to the single nozzle
configuration. The droplets electrosprayed from each nozzle exhibit the same
size and charge magnitude distributions, apart from possible effects of charge
polarity on either distribution. Thus, external neutralization is not necessarily
needed, as the atomization currents are generally balanced, and oppositely
charged droplets are mutually neutralized partially or completely through
charge transfer as they are attracted to one another by Coulombic forces and
come to contact [258]. Droplet contacts prior to solidification lead to merging
of the droplets. Solidified matrix particles with residual charge continue to
attract droplets and particles of the opposite charge, until neutralized.
Atomization current bias can be rectified as necessary by tweaking a parameter
in one of the nozzles, most importantly the liquid properties and the core or
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shell liquid flow rates, Qc or Qs (Equations 12, 15, and 18). In summary, the
basic matrix particle production in the bi-polar parallel nozzle configuration, as
compared to the corresponding single nozzle process, is essentially a scale up
that also implements particle neutralization.
The bi-polar parallel nozzle configuration can be utilized to carry out
chemical reactions in aerosol form between the oppositely charged
electrosprayed droplet species, i.e. to produce microreactors. Two different
reactants, or a reactant and a catalyst, can be electrosprayed from oppositely
charged nozzles. As the bipolar droplets are attracted to each other and
coagulate, a chemical reaction initiates within the merged droplet. For instance,
a Bakelite monomer suspension and a polymerizing catalyst (H2SO4) were
electrosprayed from separate nozzles by G. Langer and G. Yamate, and the
Bakelite polymerized in the aerosol droplets that combined with H2SO4 droplets
[232]. Other chemical reactors have been later designed using the parallel
nozzle electrospraying configuration [10,225]. A specific advantage of
electrosprayed microreactors is that the chemical reactions can be very fast and
efficient due to the small size scale [10,258]. The technique has also been used
for micro-mixing ceramic compounds, e.g. zirconium and titanium, inside
coagulated droplets [258].
H. Fu et. al. have produced coagulated, spherical dual drug nanoparticles
using the bi-polar parallel nozzle configuration, by electrospraying the two
different drug solutions from separate nozzles [259]. F. Mou et. al. have
demonstrated that electroencapsulation by using the bi-polar parallel nozzle
configuration is a feasible technique for building Janus particles –
compartmentalized colloids with two sides of different chemistry or polarity
[260,261].
By careful co-formulation of the two different electrospraying liquids,
micromatrix particles of various morphologies and compositions with a
mixture of several different payload and matrix materials could potentially be
produced with the bi-polar parallel nozzle configuration in a single-step
process, even when a single liquid that simultaneously contained all of the
materials was not suitable for electrospraying [9,12,232,236,237,240].
A more comprehensive presentation of a typical simple (nc = ns = 1) parallel
nozzle experimental electroencapsulation setup is provided in Chapter 3.2.1.
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2.3.2.3. Co-Axial Nozzles
The electroencapsulation principle for core-shell capsule production utilizing a
pair of co-axial electrospraying nozzles is depicted schematically in Figure 5c.
The immiscible core and shell liquids are electrosprayed together in CJM, with
the core liquid readily enveloped axially by the shell liquid. The shell and core
liquids can both be comprised of a single phase or a colloidal suspension. One
of the liquids can be highly dielectric, as long as the second liquid is sufficiently
conductive [9,227,236]. Charged, spherical core-shell capsules form
immediately after droplets are electrosprayed from the tip of the composite
Taylor cone. The capsule shell layer is then solidified as necessary, and the
capsules are either neutralized prior to collection or collected on an oppositely
charged electrode [9,12,236,237,242,248,262,263]. Capsule size and structure
are determined most importantly by the non-volatile material concentrations in
the electrosprayed liquids, liquid properties, the liquid flow rates Qc and Qs
[237,238,248,262,264–266].
The number of co-axial nozzles can be increased for more complex capsule
structures. Multilayered particles have been electrosprayed using tri-axial and
even tetra-axial needles [12,237,267–269]. For an increased yield, the number
of co-axial nozzle units can in principal be increased, and the units can be
arranged in arrays similarly to single nozzle electrosprays [89,91,93,95–102].
Further, layered ceramic-ceramic encapsulation has been achieved using the
co-axial configuration, for example by electrospraying alumina and zirconia
suspensions to form ceramic-ceramic composite droplets [270].
2.3.2.4. Other Methods
In addition to the electrospraying configurations discussed so far, multi-
channel needle electrospraying configurations have been utilized for the
production of asymmetric and multiphase particles and nanocolloids, such as
Janus particles, or compartmental particles of various shapes and compartment
configurations [12,271–274].
In principle, electroencapsulation could possibly be performed using an
exotic electrospraying configuration that omits capillary needles (cf.
Chapter 2.2.1). However, such techniques will not be necessary to consider for
the scope of this work.
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2.4. Oral administration of Solid Drug Materials
Oral drug administration is often the preferred method for delivering drug
materials and other therapeutic molecules to the circulatory system due to the
relative comfort, low cost, and ease of dosage control associated with the
method [275,276]. For a drug to produce the desired therapeutic effect, its
bioavailability, the fraction of the administered dose that reaches the
circulatory system without chemical degradation or decomposition, has to
suffice. An orally administered drug needs to be absorbed in a specific part of
the gastrointestinal (GI) tract; the principal absorption site for most drugs is
located in the upper and middle parts of the small intestine, the duodenum and
the jejunum [277,278]. To be absorbed, the drug must first be dissolved in the
part of the GI tract leading to the absorption site [4]. All the while, the
molecular integrity (chemical stability) of the drug must be retained [279].
Unfortunately, as many as 95% of the promising new drug candidates suffer
from poor physicochemical or pharmacokinetic properties, which greatly limits
the bioavailability of the drug when administered orally. Such disadvantageous
drug properties include low stability, low solubility and low dissolution rate in
the intestinal lumen, poor permeation of the GI tract wall, and high intestinal
or hepatic first-pass metabolism [1–4,280,281].
The discussion in the following chapters focuses on the physicochemical
and pharmacokinetic properties relevant for the oral bioavailability of solid
drug materials, as well as formulation methodology to improve these
properties.
2.4.1. Solid State of Pharmaceutical Materials
Solid matter is structurally rigid – the atoms are bound to each other tightly
and closely in a durable arrangement, unlike in liquids and gases. As observed
macroscopically, solids differ from liquids and gases in that solid matter has a
definite volume and shape, it does not flow, and it exhibits elastic stiffness
against shear stress. The atoms in a solid are immobile, although they do
oscillate around fixed points at any temperature above 0 K. The arrangement of
these fixed points constitutes the atomic structure. The atomic structure of a
solid can be either crystalline (periodically ordered) or amorphous (disordered)
[282–285].
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A crystal is a solid composed of atoms arranged in a pattern periodic in
three dimensions. This pattern is called the crystal lattice [282,285,286]. A
crystalline solid may consist of a single crystal, or more often a polycrystalline
aggregate that is composed of individual crystals (crystallites or grains). Crystals
and crystallites can vary greatly in size, upward from the nm-range
[282,287,288]. Most inorganic solids are naturally crystalline, including metals,
covalent compounds (e.g. minerals, some ceramics), and ionic compounds
(salts) [285]. Many compounds exhibit polymorphism – they can exist in more
than one crystal structure (polymorphic form) [282,289,290]. In some cases,
polymorphic forms can be distinguished by dramatic differences in physical
properties, such as morphology, stability, mechanical strength, or dissolution
rate [11,14,291]. Similarly, some elements (i.e. C) also exist in several crystal
structures. This phenomenon is known as allotropism [292,293]. A stable
crystal structure represents a local potential energy minimum of the atom
system [14,285]. An external activation energy can trigger either crystallization
or recrystallization, a solid state transformation where the atoms rearrange into
the existing or another polymorphic form [282,294–296].
In amorphous solids (or glasses), the atoms lack any vestige of long-range
order. The topologically disordered structures of amorphous solids are
stochastic in nature, although the short-range structure is not completely
random – the atoms have well-defined closest distances of approach, and hence
amorphous solids have definite, radially distributed structures relative to the
center of an average atom [284,286]. The amorphous structures can be
described well by stochastic-geometry models such as the random-close-
packing model (metallic glasses), the continuous-random-network (covalently
bonded glasses), and the random coil model (organic polymers) [284]. The
amorphous form of a substance is generally more energetic than the crystalline
form(s) [285,297]. Thus, the amorphous form is most often unstable or
metastable [6,235,297,298].
Crystallinity, the extent to which a solid is crystalline, most often lies
between the extremes of an ideal single crystal and a completely amorphous
solid. Crystals and crystallites always bear defects, manifesting as various kinds
of point, linear, and planar discontinuities or deviations from the ordered
structure. As an example, polycrystalline solids are of very high crystallinity but
are strictly speaking not completely crystalline, since the layers between
crystallites are disordered. The crystallite boundaries represent discontinuity
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surfaces of the crystal structure, and the layers in between crystallites can be
viewed as planar defects, or amorphous regions [282,299].
2.4.1.1. Drug Structural Stability
Most drug materials tend to form crystals in room conditions, and are
formulated in a crystalline form in drug products [14,289]. The amorphous
drug form is structurally unstable, thus it tends to crystallize spontaneously
(Chapter 2.4.1). Similarly, some of the polymorphic forms may tend to
recrystallize into a structurally more stable polymorphic form. To stabilize the
solid form of the drug completely or to a certain extent, the drug can be
dispersed as crystalline or amorphous particulates across the volume of solid
excipient (e.g. a polymer) particles, in a solid dispersion formulation
(Chapter 2.4.3) [7,234,240]. At the extreme dispersity, the drug is dispersed in a
molecular form, to form a solid solution with the excipient (Chapter 2.4.3)
[7,300]. The rate of solid state transformation depends not only on the
structural energy difference of the solid states, but also on the dispersity and
mobility of the drug molecules in the formulation [14,296,301]. The drug
molecular mobility depends on the excipients and spatial confinement of the
drug in the formulation, as well as the storage conditions (T, p, and humidity)
[6,302,303]. The storage conditions influence the stability of the drug
amorphous form, and the comparative structural stability of polymorphic
forms [235,289,297,304,305].
 The crystallinity and polymorphic form of the drug can crucially affect its
physico-chemical properties, such as the dissolution rate [14,289,306].
Therefore, a solid state transition of an unstable form of the drug, for instance
crystallization of an amorphous form due to incorrect storage conditions, could
lead to a diminished dissolution in oral administration, posing a bioavailability
barrier that could ultimately result in an inadequate therapeutic effect of the
drug (Chapter 2.4.2).
At temperature T, the Gibbs free energy difference ∆G = ∆H − T∆S
obtained from solubility and melting data is a quantitative measure of the
stability relationship between polymorphs, where the enthalpy term ∆H results
from the structural (lattice) energy difference between polymorphs, and the
entropy term T∆S results from disorder and thermal vibration difference [297].
The reduced stability of the amorphous form is due to a generally higher
free energy G, as compared to the crystalline forms. The excess free energy G of
amorphous solids can be obtained from solubility or vapor pressure data,
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similarly to crystalline solids [297]. The excess free energy consists in part of
the excess enthalpy H, measurable from heats of solution or crystallization
[297,301]. Some of the excess free energy is due to the molecular mobility,
which in amorphous solids is generally not zero. The mobility is related to
excess entropy, obtainable indirectly from TS = H – G [303].
2.4.1.2. Drug Solubility
The true solubility (saturation solubility) s of a solid substance (solute) in a
solvent is the maximum amount of solute that can be dissolved per unit volume
of the solvent before the solution becomes saturated. The true solubility s of a
solute in a particular solvent is an intrinsic property of the solute molecule that
depends on T and p [5].
The apparent solubility (or simply, solubility) sapp is distinct from true
solubility s; in certain conditions, the solute concentration C can temporarily or
locally exceed the saturation limit (C > s) [7,307,308]. This abnormal,
supersaturated state of a solution is thermodynamically unstable [308]. Over
time, the solution will spontaneously approach a uniformly saturated state
where solute diffusion, dissolution and precipitation are in a dynamic
equilibrium [5,308]. An undersaturated (or unsaturated) solution (C < s)
approaches saturation only with a large enough excess of the solid submerged
in the solution.
In oral drug administration, the aqueous solubility of the drug at 37°C in the
pH range of the GI tract (1.2–6.8) is relevant [281]. Poor water-solubility of the
drug very commonly hampers or prevents sufficient dissolution of the drug
prior to its migration to the optimal absorption site in the GI tract, leaving the
bioavailability of the drug lacking (Chapter 2.4.2.1) [4,5]. The apparent
solubility sapp of the drug can be enhanced by formulation of the solid state: sapp
generally varies by polymorphic form according to ∆H [14,297,306];
furthermore, the amorphous form can exhibit a significantly higher sapp as
compared to the crystalline forms, due to the higher G [6,235,307–309]. The
extreme sapp is achieved for molecules released to a liquid solution from a solid
solution, where the drug is readily dispersed in a molecular form
(Chapter 2.4.3) [7,300].
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2.4.2. Oral Bioavailability of Drugs
An orally administered drug product is usually designed, at the very least, to
stabilize the drug in a pre-formulated solid state until its release, and to target
the release in a certain section of the GI tract. During or after its release, the
drug material must undergo a chain of processes before the drug molecules
reach the circulatory system – most importantly, drug dissolution, permeation,
and exposure to first-pass metabolism. Each of these processes potentially
limits the attainable oral bioavailability of the drug. In the following Chapters,
enhancement of the relevant physicochemical and pharmacokinetic drug
properties by formulation for oral administration is discussed.
2.4.2.1. Drug Dissolution
The dissolution rate dC/dt of a solid substance can be expressed by the







where A is the total contact area of the solid substance and the solution, D is the
diffusion coefficient of the solute in the solution, C is the solute concentration
and h is the thickness of the diffusion boundary layer at the solid-liquid
interface. The dissolution model described Equation 20 demonstrates the
reasoning for various strategies to improve drug dissolution in the GI tract.
A very common strategy to improve drug dissolution rate is to increase A in
Equation 20. This can be achieved by decreasing the drug particle size, by
increasing the porosity of drug particles, or by improving the wetting properties
of the drug particles [4,5,7,235,309,312]. Another important means to improve
drug dissolution rate is enhancement of sapp, which is possible by formulation of
the drug in an optimal polymorphic form, or for better results, amorphous or
molecular form (Chapters 2.4.1.2 and 2.4.3). The molecular form of the drug
also represents the highest attainable A in the formulation. In consequence to
the enhanced sapp, the drug dissolution burst can supersaturate the luminal
fluid.
Usual methods for drug amorphization and particle size reduction include
freeze drying, spray drying, and milling, for example [5,6,297,313,314].
However, these methods inflict significant physical or thermal stress on the
drug, which may lead to degradation of sensitive drug materials [5]. In
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addition, the micronized powder may agglomerate to a degree in some cases,
which negates the benefit of comminution [7].
Lately, electrospraying of a drug solution has been shown to be a valid
single-step method for the production of amorphous or crystalline drug micro-
and nanoparticles [10,12,315]. The size, crystallinity, or even porosity of the
electrosprayed drug particles have been shown to be adjustable in many
scenarios by varying the electrospraying parameters [9,13,83,113]. In several
studies, various electrosprayed bio- and drug materials have been shown not to
degrade in the process [9,12,113,242,316,317].
Improving sink conditions in the intestinal lumen to reduce C on the right-
hand side of Equation 20 is beneficial for maintaining the dissolution rate
dC/dt at a high level for further dissolving drugs [318]. Of course, the effect on
drug bioavailability directly depends on the pharmacokinetic nature of the sink.
Changes in hydrodynamics to influence h are difficult to implement in vivo [7].
Moreover, D varies between subjects and event within subjects according to the
fed and fasted state [300]. The total drug dissolution can be improved to some
extent by administrating the drug in a fed state, which increases the time
available for dissolution, and could also improve the dissolution rate [7,319].
2.4.2.2. Intestinal Drug Permeation
The rate of intestinal drug permeation (transepithelial transport), i.e. the flow
of the dissolved drug molecules through the intestinal wall, is proportional to
the drug concentration gradient across the membrane, and the intestinal
permeability of the drug [3,4,281,308]. Thus, ample drug dissolution is
advantageous for reaching sufficient drug permeation. Drug permeability
depends on the drug lipophilic and hydrophilic properties, and the properties
of the membrane at the permeation site such as pH, mucus production, and
intercellular Ca content [4,281,320].
Drug permeation acts to enforce sink conditions in the intestinal lumen,
while benefiting the drug bioavailability (Chapter 2.4.2.1). Therefore in certain
scenarios, enhancing the drug permeability can also significantly improve the
drug dissolution rate in the GI tract. Consequently, research has been
conducted to improve drug permeation i.e. by the use of suitable excipients
[321,322]. According to the dissolution model of Equation 20, the effect of
increasing the permeation rate to the drug dissolution rate remains quite
limited, unless the permeation rate is initially significantly lower than the
dissolution rate. Furthermore, if the intestinal fluids at the permeation sites
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saturate, and if the drug bioavailability is limited by its permeation rate rather
than the dissolution rate, then attempts to increase dissolution rate without also
either boosting sapp or enhancing the intestinal permeability to improve sink
conditions would yield no further benefit to bioavailability.
2.4.2.3. First-Pass Metabolism
In the course of transit towards the circulatory system, an orally administered
drug material eventually comes to contact with or dissolves to the digestive
fluids in the GI tract. Thus, the drug is exposed to intestinal metabolism, which
can be catalyzed by various enzymes mainly in the oral cavity, stomach, and the
small intestine [320,323,324]. Drugs that go on to permeate the GI tract wall are
further exposed to hepatic metabolism, before allowed to the circulation for the
first time [4,320,325]. These degrading and decomposing biotransformation
processes constitute the most important phases of drug first-pass metabolism,
which can severely limit the drug oral bioavailability [5,281,323,325].
2.4.3. Drug Carrier Formulations to Improve Oral Bioavailability
Traditionally, orally administered solid drug formulations consist of compacts
(tablets) of micronized drug material and excipients. Several compacts can be
packaged in a dosage form to a pH-sensitively soluble capsule for an extra layer
of protection and release targeting.
These kinds of basic dosage formulations may not provide adequate oral
bioavailability for drugs of unfavorable physicochemical or pharmacokinetic
properties, such as poor solubility. The limiting physicochemical or
pharmacokinetic properties can be improved for example by nanosizing and
amorphization of the drug (Chapter 2.4.2), to approach a sufficient drug
bioavailability for the oral route of administration to become feasible. In such
advanced formulations, it is often subsequently necessary to stabilize the drug
solid state for the duration of the drug product being stored, and furthermore
during the initial stages of oral administration until the drug is released. Solid
state stabilization by physical confinement of the drug material can be carried
out in many ways: by utilizing excipients as drug stabilizing binders to form
eutectic mixtures [7,326], solid dispersions [240,309], or amorphous solid
solutions [7] (Chapter 2.4.3.1); by integrating the drug molecules into the
crystal structure of the drug carrier material to form crystalline solid solutions
[7] (Chapter 2.4.3.1), or co-crystals [327,328]; or by loading the drug to a
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biocompatible carrier host, such as suitable porous Si micro- or nanoparticles
[16,276,329,330] (Chapter 2.4.3.2).
2.4.3.1. Drug Solid Dispersions and Solid Solutions
The solid state and dispersity of a drug can in many cases be sustained or
stabilized by formulating the drug as a (phase separated) solid dispersion or a
solid solution [7,235,300,331–335]. Originally conceptualized by Sekiguchi and
Obi in 1961 [326], a phase separated drug solid dispersion consists of
amorphous or nanocrystalline drug particulates distributed uniformly across
the volume of a binding and stabilizing excipient (solvent), such as a suitable
hydrophilic polymer [7,240]. Some widely used solvent polymers include e.g.
polyvinylpyrrolidone (PVP), and polyethylene glycols (PEGs)
[5,300,332,333,336]. A molecularly dispersed drug (solute) forms a solid
solution with the solid solvent [7,300]. In amorphous solid solutions, the solute
molecules are dispersed homogenously in a disordered, rigid network formed
by the solvent molecules (cf. Chapter 2.4.1) [7,300]. Crystalline solid solutions
are substitutional or interstitial: the solute molecules substitute solvent lattice
molecules or occupy interstices in the solvent lattice, depending principally on
the relative size difference of the solvent and solute molecules [7,300]. A solid
solution is analogous to a liquid solution in the sense that both consist of a
single phase of matter [7]. The fundamental difference between solid and liquid
solutions is found in the mobilities of both the solute and the solvent molecules.
In phase separated solid dispersions and solid solutions, the drug
particulates are held in place mechanically to a degree by the solid structure.
More importantly, the surface molecules of drug particulates and single drug
molecules are bound to the excipient by chemical interactions (e.g. hydrogen
bonding), constricting or even practically halting the long-range movement of
drug molecules (Chapter 2.4.1.1) [313,337,338]. Thus, the processes of drug
particle agglomeration and solid state transformation can be slowed down, or
prevented altogether (Chapter 2.4.1.1) [94,300,305,339,340]. In effect, the drug
is temporarily suspended in either a disordered state (molecular dispersion or
amorphous particulate dispersion); or a state of reduced order (nanocrystalline
particulate dispersion), as compared to the bulk or micronized powder states
[7,94,335,341]. Furthermore, solid dispersion and solid solution formulations
can maintain a significantly increased surface area A of the dispersed drug
material available for dissolution for an extended period of time. Consequently,
the dissolution rate of a poorly soluble drug from solid dispersion or solid
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solution formulations can be greatly enhanced (Chapter 2.4.2.1) [333,342,343].
However, it can be challenging to formulate a sufficiently stable solid dispersion
or solid solution of a specific drug in order to prevent its crystallization and
retain the enhanced drug dissolution properties over extended periods of time
in storage [344,345].
Drug solid dispersion and solid solution formulations can be prepared for
example by spray-drying [300,334], freeze-drying [300,335,346], or by the hot-
melt method [5,300,345]. Lately, electrospraying has emerged as an alternative
method in the production of solid dispersion and solid solution drug
formulations. By electrospraying a common solution or melt of the drug and
excipients, and subsequent solvent evaporation or cooling, very small and
monodisperse drug loaded matrix particles can be produced in a single-step
electroencapsulation process, as further discussed in Chapter 2.3
(Electroencapsulation) [94,153,154,240,252,253,256].
Orally administered solid dispersion and solid solution formulations of a
drug are designed to maintain the solid state and dispersity of the drug until it
is released or directly dissolved to the fluids in the GI tract. The drug release
triggering conditions and release kinetics, and thus the in vivo release site and
drug release rate, are influenced by the composition, size, porosity and
morphology of the carrier particles, the solid state and distribution of the drug
material within the carrier particles, as well as biological factors
[7,253,300,347]. Drug release targeting can minimize unnecessary exposure of
the drug to intestinal metabolism, as well as possible drug-induced side effects
to the gastric walls [323,324,348]. The dissolved drug concentration C at the
absorption site can be maximized by drug release targeting to promote drug
absorption [277,278,349]: the release of a poorly soluble drug from a solid
solution often supersaturates the gastrointestinal fluid locally (Chapter 2.4.1.2),
potentially enhancing the transepithelial transport of the drug (Chapter 2.4.2.2)
[300].
2.4.3.2. Drug Loading to Porous Silicon Particles
The feasibility of mesoporous (pore size 2–50 nm) silicon (PSi) micro- and
nanoparticles as functional drug carriers to enhance the oral bioavailability of
various poorly soluble, poorly permeable, or otherwise problematic drug
materials have been researched extensively, with promising results [16–
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biocompatible carrier host, such as suitable porous Si micro- or nanoparticles
[16,276,329,330] (Chapter 2.4.3.2).
2.4.3.1. Drug Solid Dispersions and Solid Solutions
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hydrophilic polymer [7,240]. Some widely used solvent polymers include e.g.
polyvinylpyrrolidone (PVP), and polyethylene glycols (PEGs)
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molecules are dispersed homogenously in a disordered, rigid network formed
by the solvent molecules (cf. Chapter 2.4.1) [7,300]. Crystalline solid solutions
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the relative size difference of the solvent and solute molecules [7,300]. A solid
solution is analogous to a liquid solution in the sense that both consist of a
single phase of matter [7]. The fundamental difference between solid and liquid
solutions is found in the mobilities of both the solute and the solvent molecules.
In phase separated solid dispersions and solid solutions, the drug
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drug molecules (Chapter 2.4.1.1) [313,337,338]. Thus, the processes of drug
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prevented altogether (Chapter 2.4.1.1) [94,300,305,339,340]. In effect, the drug
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material available for dissolution for an extended period of time. Consequently,
the dissolution rate of a poorly soluble drug from solid dispersion or solid
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solution formulations can be greatly enhanced (Chapter 2.4.2.1) [333,342,343].
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Drug solid dispersion and solid solution formulations can be prepared for
example by spray-drying [300,334], freeze-drying [300,335,346], or by the hot-
melt method [5,300,345]. Lately, electrospraying has emerged as an alternative
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potentially enhancing the transepithelial transport of the drug (Chapter 2.4.2.2)
[300].
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stage  [17,276,329,354,355,361]. Thus, the PSi particles can be tailored to favor
adsorption of certain molecules or cells [17,276,329]; the drug release rate can
be controlled [329,362]; all the while making the PSi particles biocompatible
[353,355,357]. The ratio of PSi surface area available for drug loading to the
mass of the PSi particles can be as high as 100–800 m2/g [276,361].
Temperature sensitive drugs such as proteins and peptides (e.g. insulin) can be
loaded to the pores of PSi particles without risking thermal degradation, as
loading is possible in room temperature solutions [17,276,354,363,364]. In
addition, the photonic properties of PSi can potentially be harnessed for
tracking the drug delivery process [329].
The drug loaded in the PSi pores is effectively dispersed as clusters separated
by pore walls. At high enough drug payloads in the PSi pores, the drug partially
begins to crystallize on the surface of PSi particles during the loading process,
which is usually avoided by moderating the loading degree, or remedied by
rinsing the particles after loading [350,365]. The total free surface area A of a
drug loaded to the pores of PSi particles can be very large, although it is
inevitably smaller than the PSi total surface area available for drug adsorption.
In sufficiently small pores, the crystallization of the drug molecules may be
prevented by spatial confinement exerted on the drug molecules by the pore
walls, and the loaded drug remains at least partially in an amorphous form
[302,351,365]. These qualities, together with the wetting properties of the PSi
particles in certain cases [17], can result in a greatly increased dissolution rate
of the loaded drug (Chapter 2.4.2.1) [17,276,302,351]. In addition, the
permeation of the loaded drug across Caco-2 and Caco-2/HT29 intestinal-
derived cell monolayers have been reported to improve in some scenarios
[18,352,354,366].
Nanoparticles in general tend to form aggregates due to Van der Waals
attraction and other interactions [367–369]. Thus, the physical handling and in
vivo dosing of PSi nanoparticles remain a considerable challenge. Another
difficulty lies in the optimal drug release targeting from PSi. In certain
scenarios, the drug can be prematurely released, which could unnecessarily






Griseofulvin is an antifungal drug first isolated in 1939 [371]. Classified as a
Biopharmaceutics Classification System (BCS) class II (low aqueous solubility,
high permeability) drug, the low dissolution rate of griseofulvin limits its GI
absorption, and therefore oral bioavailability [372]. The apparent solubility of
crystalline griseofulvin in H2O at room temperature is ca. 8–10 µg/ml within a
wide dispersion concentration range, practically independently of the pH
[17,307,373–376]. Griseofulvin has a high tendency to crystallize, even at room
temperature and low humidity, and its crystallization rate is very fast
[296,377,378]. Because of these properties, griseofulvin (Orion Pharma,
Finland, and Sigma-Aldrich, U.S.A.) was selected as a model drug for
electroencapsulation in micromatrix particles (papers I and III).
Piroxicam is non-steroidal anti-inflammatory drug of BCS class II [372,379].
Piroxicam exhibits tautomerism and polymorphism [380,381]. Previously, the
crystal structures of three polymorphs have been calculated and verified
experimentally: form I, form II, and form III [290,381–384]. In addition, α1-
form (previously also α-form) has been reported, but its existence has not been
verified [383,385]. Finally, the structure of piroxicam monohydrate crystal has
been calculated and verified experimentally [386]. Form I is the most stable
form in ambient conditions, and used for electrospraying liquid formulation in
paper II (Hawkins Pharmaceuticals, U.S.A.).
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3.1.2. Polymers
Eudragit L 100 and Eudragit L 100-55 (Evonik Industries, Germany) are enteric
methacrylate copolymers that dissolve in water above the threshold pH of 6.0
and 5.5, respectively. Eudragit L 100 and Eudragit L 100-55 were used as the
polymer matrix material in micromatrix particles produced in papers I and III.
Eudragit E 100 (Evonik Industries, Germany) is a cationic copolymer,
water-soluble below pH 5.0. In papers I and IV, Eudragit E 100 was used as the
shell polymer in electrosprayed core-shell microcapsules.
3.1.3. Solvents and Additives
In papers I and IV, analytical-grade glycerol (99.9% purity, MP Biomedicals,
Solon, OH) was the base solvent in microcapsule core liquid electrospraying
formulations. The core liquid conductivity Κc was controlled by NaI (Merck,
Germany) doping, and heating. The effects of NaI concentration CNaI and
temperature T on Κc were measured using a HI 8033 conductivity meter
(Hanna Instruments, Romania) in paper I, and a Zetasizer Nano series zeta
potential measurement instrument (Malvern, U.K.) in paper IV. Generation of
submicron NaI-doped glycerol droplets by electrospraying has been previously
reported [130,149]. In papers I and III, glycerol was also used as an anti-static
plasticizer in micromatrix particles.
In papers I, II, and IV, analytical-grade chloroform (99.0% purity, Merck,
Germany) was the base solvent in microcapsule shell liquid and drug particle
electrospraying formulations. In papers I and III, ethanol (99.5% purity, Altia,
Finland) was used as the base solvent in micromatrix particle electrospraying
liquid formulations. Fine (< 53 µm) particles of talc (Ciba Specialty Chemicals
Oy, Finland) were dispersed as an anti-tack agent in the micromatrix particle
and microcapsule shell liquid electrospraying formulations (papers I, III, IV).
Dichloromethane (DCM; Merck KGaA, Germany) was used as a drug
loading solution in papers I and III.
3.1.4. Mesoporous Silicon Particles
In the present work, PSi micro- and nanoparticles (cf. Chapter 2.4.3.2) were
manufactured from Si wafers (Siegert Wafer GmbH, Germany, or Cemat
Silicon, Poland), using previously reported methods, as specified per surface
chemistry.
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For paper I, thermally carbonized PSi (TCPSi) microparticles were
manufactured, using a previously reported method [17]. For papers I and III,
thermally oxidized PSi (TOPSi) nanoparticles were manufactured [356], with a
hydrodynamic diameter (Z-average) of 163.0 nm, and polydispersity index
(PdI) of 0.094 as measured for paper III. For paper IV, TCPSi nanoparticles
with a hydrodynamic diameter of 147.0 nm, and PdI of 0.109, were
manufactured [356,357,387].
In papers I and III, griseofulvin was loaded to the pores of TOPSi
nanoparticles in a DCM loading solution. Griseofulvin has previously been
experimentally loaded in an amorphous form into the pores of TCPSi
microparticles, thermally hydrocarbonized PSi (THCPSi) microparticles, and
TOPSi nanoparticles as a model drug in research of oral drug delivery and
controlled release applications [17,18,302].
3.1.5. Phosphate-Buffered Saline
Phosphate-buffered saline (PBS) is a test solution used for in vitro dissolution
experiments to simulate the small intestine conditions [219,277,357]. For
paper III, PBS with a phosphate molar concentration of 0.02 M was prepared by
dissolving 7.81 mmol of KH2PO4, 12.21 mmol of K2HPO4·3H2O, and 0.146 mol
of NaCl in 1000 ml of deionized water, which was produced using a Direct-
Q 5 UV system (Merck Millipore, U.S.A.). The final pH was adjusted to
6.80 ± 0.02 by adding HCl (Oy FF-Chemicals Ab, Finland).
3.2. Methods
3.2.1. Electrospraying Methods
3.2.1.1. Bi-Polar Parallel Nozzle Electroencapsulation
In papers I, III, and IV, core-shell microcapsules and micromatrix particles
were produced using a versatile bi-polar parallel nozzle electroencapsulation
setup. The electroencapsulation parameters (atomization voltages; liquid flow
rates; geometry of the nozzles, electrodes, and electrospraying chamber; liquid
composition and properties; ambient, nozzle, and chamber temperatures) vary
in part between the papers, but the parameter ranges are outlined in this
chapter. The latest variation of the setup (paper IV) is depicted in Figure 6.
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Figure 6. a) The bi-polar parallel nozzle electroencapsulation setup used for the
experimental work in paper IV. b) Simulated electric field lines and equipotential
curves (0.26 kV division) in the vicinity of the electrospraying nozzles, shown for
nozzle voltages Us = +3.25 kV and Uc = −3.77 kV. A photograph (1.00 ms exposure) of
the combining oppositely charged electrosprayed droplets is inserted in the actual
position and scale. c) Detailed cross-section of the core liquid electrospraying
geometry. For both nozzles, a = 10.0 mm, c = 2.0 mm, h = 4.0 mm, Ø = 12.0 mm. d)
Photograph of NaI-doped glycerol (NaI concentration CNaI = 0.50 mg/ml) being
electrosprayed from the core liquid nozzle at Uc = −3.75 kV, liquid flow rate of
Qc = 0.50 ml/h, and nozzle outer and inner diameters of do = 0.30 mm and
di = 0.15 mm. e) Encapsulation of the electrosprayed droplets. f) Solvent evaporation
from the capsule shell layer during capsule fall. g) Collection of the solid-shell capsules
in the bottom of the chamber.
As depicted in the top of Figure 6a, the dual-capillary electrospraying device
used for the electroencapsulation setup consisted of a pair of conductive and
heatable capillaries angled 20° relative to the vertical, connected to guard
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electrodes of diameter 36.0 mm, and kept in oppositely signed high potentials
Ui using two high-voltage DC-DC converters (Spellman MM-series, U.K.). The
capillaries penetrated a circular, insulating polyoxymethylene (POM) lid.
Electrospraying voltages of magnitudes 2.9–5.6 kV were used (throughout
papers I, III, and IV) for CJM electrospraying. Liquid flow rates Qi were
controlled using a pair of syringe pumps (New Era Pump Systems, Inc., NE-501
model, U.S.A.). Flow rates Qi of 0.25–3.00 ml/h were used. The extractor plate
electrodes (Figures 6b–c) were of thickness c = 2.0 mm, outer diameter of
36.0 mm, and with a round hole of diameter Ø = 12.0 mm in the middle. The
extractor electrodes were suspended from the capillaries using insulating
materials (not shown in Figures 6a–c), and grounded. The adjustable inter-
electrode distance a was 9–10 mm, identically for both of the capillaries in each
paper. Precision stainless steel dispensing tips (EFD, U.S.A.) of inner diameters
di of 0.15–0.51 mm were used as spraying nozzles. Both nozzle tips were
positioned identically, a distance h of 4–5 mm above the extractor (ground)
electrode (Figure 6c). In Figure 6d, a close-up photograph of the Taylor cone is
shown for NaI-doped glycerol, the core liquid electrosprayed in papers I
and IV.
The POM lid holding the dual-capillary electrospraying device sealed the
top of a steel electrospraying chamber, which was grounded (Figure 6a). Two
electroencapsulation chambers of different sizes were used, each consisting of
an open-ended cylinder, complete with a pair of air-tight observation windows
and a ventilation channel in the upper part of the chamber. Each chamber was
depressurizable and heatable. The chamber temperature T was 20–70°C, and
controlled using a temperature control unit (Meyer-Vastus, Finland), and a
heating cable (Horst, Germany) coiled around the chamber. Shown in
Figure 6a is the large chamber (height 1040 mm, inner diameter 210 mm), used
in papers III and IV. The small chamber, of height 740 mm and inner diameter
110 mm, was used for electroencapsulation in paper I.
In Figure 6b, a closer view of the electrospraying nozzles and the
encapsulation region below the extractor electrodes is shown. Simulated electric
field lines and equipotential lines are shown for the electroencapsulation
parameters of paper IV with no droplets present, and the shell and core nozzle
voltages Us and Uc set asymmetrically. As can be observed, the electric field is
strong and axisymmetric close to each of the nozzles and between the
electrodes to suffice for CJM electrospraying of each liquid. However, in the
encapsulation region, the external electric field is very weak, and the field
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voltages Us and Uc set asymmetrically. As can be observed, the electric field is
strong and axisymmetric close to each of the nozzles and between the
electrodes to suffice for CJM electrospraying of each liquid. However, in the
encapsulation region, the external electric field is very weak, and the field
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generated by electrosprayed droplets would easily become significant.
Therefore, as discussed in Chapter 2.3.2.2., effective combination and
neutralization of the oppositely charged electrosprayed droplets through
mutual Coulombic attraction and contact charge transfer was possible in the
encapsulation region (Figure 6e). This is further illustrated by the photograph
in Figure 6b, where the typical momentary shapes of the electrosprayed droplet
clouds are shown in the encapsulation region.
During the fall of the formed neutral capsules (or micromatrix particles)
inside the electrospraying chamber (Figure 6f), excess solvent was evaporated
from the capsule shell layers (particles). Where necessary, heating was applied
to enhance the evaporation rate, thus ensuring complete solidification of the
capsule shell layers (particles) prior to collection (Figure 6g).
3.2.1.2. Electrospraying of Drug Particles
In paper II, drug microparticles were produced by electrospraying in CJM into
the depressurizable, grounded small chamber described in Chapter 3.2.1.1. A
vertically aligned axisymmetric single-nozzle electrospraying device was
integrated to a flat steel lid which closed the top of the electrospraying chamber.
The electrospraying device consisted firstly of an electrospraying capillary,
which penetrated the center of the chamber lid and was electrically isolated
from it. The capillary was kept in positively signed high voltage, and penetrated
an equipotential circular guard plate electrode inside the electrospraying
chamber. A grounded circular extractor plate electrode with a hole in the center
was suspended ca. 1 cm beneath the electrospraying nozzle, parallel to the
guard electrode. The electrosprayed droplets were neutralized by a negative
polarity Corona neutralizer (cf. Chapter 2.1.4.3.), which was attached off-center
underneath the extractor electrode, and pointed perpendicularly to the droplet
trajectory passing through the extractor electrode hole. Additional details of the
electrospraying apparatus are provided in previously published work [113].
The electrospraying was conducted in room temperature. Where necessary,
the solvent evaporation rate from the droplets was improved by depressurizing
the electrospraying chamber. Pressures p of 0.5–1.0 bar were used. The
electrospraying parameters are described in more detail in paper II, and
previously published work [113].
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3.2.2. Atomization Current Measurement
Atomization current I was determined using the control and measurement
circuit shown in Figure 7, where Uε is the source voltage. As detailed in
paper IV, for liquid flow rate Q, the current fed by the circuit to the atomization










where R = 500 MΩ (thick film resistor, Ohmite, Mexico), R1 = 999 MΩ and
R2 = 1.11 MΩ were voltage divider resistances (Emco High Voltage
Corporation Model V1G, U.S.A.), RV = 10.0 MΩ was the internal resistance of
the multimeters (Fluke 79 III, U.S.A.; and YFE YF-3503, Taiwan) used for
monitoring voltages VA and VB. To obtain IN(Q), the voltage VA−B  was
measured with high precision using an electrometer (Keithley 6514, U.S.A.).
Due to the high internal resistance (REM > 200 TΩ) of the electrometer,
IEM << VB/RV and VA−B ≈ VA − VB. The current IN(Q) was measured at least eight
times as averages over periods of 30 s for each investigated value of Q. The
time-dependent baseline IN(Q = 0) was determined similarly, in-between
measuring the IN(Q) data sets for each Q > 0. The observed current difference
I(Q) = IN(Q) − IN(0) consisted principally of the atomization current at liquid
flow rate Q and the capacitive charging current of the liquid. The capacitive
charging current was minimized by allowing the system to stabilize for 5–
10 min prior to each set of current measurements, as detailed in paper IV.
Figure 7. The electrospraying control circuit used for the measurement of atomization
current I(Q) = IN(Q) − IN(0).
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3.2.3. Weighing
The accurate and repeatable weighing of the produced microcapsule samples
was especially important in paper IV, and care was taken in the weighing
procedure. An AG245 analytical balance (Mettler Toledo, U.S.A.) was
electrostatically shielded and grounded, and then used for the measurements.
The precision setting was 10−5 g. The electroencapsulated samples were weighed
while in the pre-weighed Petri dishes used for sample collection. The collection
dish was placed in a tight fitting Al enclosure, which was grounded in situ
before recording its weight. A centered and repeatable weight distribution on
the scale platform was ensured by a fixed metal ring on the platform. Drift was
accounted for by letting the scale settle for 5 minutes in each measurement
before reading the weight. The measurements were repeated. Any erroneous
measurements due to unwanted contacts or improper closure of the Al sample
pan were discarded and restarted immediately.
3.2.4. Optical Microscopy
The integrity of the produced microcapsules and micromatrix particles were
assessed on-site during coarse electrospraying parameter adjustments using an
optical microscope (Olympus BH-2, Japan). The size distributions of the
produced microcapsules and micromatrix particles (papers I, III, and IV), as
well as calibration droplets (paper IV), were determined from microscope
images, captured using a mounted camera (Canon Powershot A630, Japan).
The images were analyzed using ImageJ 1.47v software (Wayne Rasband, NIH,
U.S.A.) to obtain the projection areas Ai of the imaged objects.
3.2.5. Scanning Electron Microscopy
During the experimental work for paper I, preliminary capsule batches were
imaged using an S200 scanning electron microscopy (SEM) system (Cambridge
Instruments, Cambridge, UK) to provide additional information on the capsule
shapes and integrity (images not published).
In paper II, samples of the produced piroxicam particles were imaged using
a Vega SB SEM system (Tescan U.S.A., Warrendale, PA, U.S.A.). The particle
size distribution was analyzed from the images using Image-Pro Plus 1.3
software (Media Cybernetics, Inc., Rockville, MD, U.S.A.).
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3.2.6. Transmission Electron Microscopy
In paper III, TOPSi nanoparticles electroencapsulated in micromatrix particles
were imaged by transmission electron microscopy (TEM), using a JEM-
1400Plus microscope (Jeon, Japan).
3.2.7. X-Ray Computed Tomography
In paper I, the structure of microcapsules and distribution of the PSi particle
payload was analyzed by micro- and nanoscale X-ray computed tomography
imaging, using a SkyScan 1172 µCT (Belgium), and an Xradia nanoCT (U.S.A.)
imaging equipment.
3.2.8. X-Ray Diffraction
The crystal structures of each crystalline compound, and their polymorphic
forms, are in general different. Thus, the measured X-ray diffraction (XRD)
pattern of each crystal lattice is usually unique. More specifically, the crystal
system and crystal parameters determine the possible diffraction angles 2θ of
monochromatic X-rays (of wavelength λ), according to the Bragg law:
λ = 2dhklsinθ, where dhkl is the interplanar distance of the diffracting lattice
planes hkl. The relative intensities of the measured diffraction peaks are
influenced by the overall electron configuration in the lattice, as well as the
preferred crystal orientation (texture) in the measured sample. Amorphous
solids do not diffract X-rays. However, the presence of significant amorphicity
can be detected in an XRD measurement: X-ray scattering from any
amorphous solid produces a characteristic, very broad intensity maximum to
the measured diffractogram. Its position (d-value) relates to the average nearest
neighbor inter-atomic distance in an amorphous solid (cf. Chapter 2.4.1),
which is a few Ångströms [282,286].
In papers II and III, the integrity and purity of the raw pharmaceutical
compounds was validated by XRD measurements. Furthermore, the
crystallinity, polymorphic forms, and stability of the electrosprayed
pharmaceutical compounds were analyzed. The measurements were carried out
mostly with an X’Pert Pro MPD diffractometer (PANalytical, Netherlands;
papers II and III), and additionally with a Scintag X-1 XRD system (Scintag
Inc., Cupertino, CA, U.S.A.; paper III). In both systems, Cu-Kα radiation
(λ = 1.541874 Å) was used.
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In paper III, a variable temperature X-ray diffraction (VTXRD)
measurement was performed at temperatures of 28–195°C to observe the
recrystallization of electrosprayed piroxicam to form I. In the VTXRD
measurement, the X’pert Pro MPD system was used with a TTK 450 sample
heating chamber (Anton Paar, Graz, Austria).
3.2.9. Thermogravimetric Analysis
A thermogravimetric analysis (TGA) was used to determine the coarse
griseofulvin loading degree in TOPSi nanoparticles (paper I) [17,388]. In
paper IV, TGA was performed to investigate the average ratio of core and shell
material mass in the produced microcapsule samples. The microcapsule
samples were heated from 25°C to 950°C at a rate of 25.0°C/min. A TGA 7
thermogravimeter (PerkinElmer, Waltham, MA, U.S.A.) was used for the
measurements.
3.2.10. Differential Scanning Calorimetry
Differential scanning calorimetry (DSC) was used to estimate the proportion of
loaded griseofulvin within the pores of TOPSi nanoparticles in paper I [17,388].
Furthermore, DSC was used as a supplementary thermal analysis method to
verify the crystallinity, polymorphic form and stability properties of the drug
materials in electrosprayed piroxicam particles (paper II) and micromatrix
particles containing griseofulvin solid dispersions (paper III). All of the DSC
measurements were carried out using a Pyris Diamond differential scanning
calorimeter (PerkinElmer, Waltham, MA, U.S.A.). The instrument was
calibrated using In references. The samples were sealed in Al sample pans, and
measured under a N2 purge gas flow. In papers II and III, a heating rate of
10°C/min was used.
3.2.11. High Performance Liquid Chromatography
High performance liquid chromatography (HPLC) analysis was performed in
paper II to detect degradation products in the electrosprayed piroxicam
particles. In paper III, the griseofulvin concentrations Cgr in the in vitro
permeation experiments were determined using HPLC at a detection
wavelength of λ = 292 nm (Chapter 3.2.16). An Agilent 1100 Series HPLC
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system (Agilent Technologies, Waldbronn, Germany) was used for all of the
measurements.
3.2.12. Raman Spectroscopy
Raman spectra of the piroxicam particles produced in paper II were measured
using an InVia spectrometer (Renishaw, Wotton-under-Edge, U.K.), to obtain
additional structural comparison information between the electrosprayed
piroxicam and form I piroxicam. A laser excitation wavelength of λ = 785 nm
was used.
3.2.13. Fourier Transform Infrared Spectroscopy
In paper II, Fourier transform infrared (FTIR) spectra of the electrosprayed and
form I piroxicam were measured with a Spectrum BX spectrometer
(PerkinElmer, Waltham, MA, U.S.A.), using MIRacle attenuated total
reflectance accessory (Pike Technologies Inc., Madison, WI, U.S.A.).
3.2.14. UV/Vis Spectroscopy
The griseofulvin loading degree in TOPSi nanoparticles was measured in
paper III by ultraviolet/visible (UV/Vis) spectrophotometry. Furthermore,
UV/Vis spectroscopy was used for the measurement of the degree of
griseofulvin dissolution from free griseofulvin, as well as micromatrix particle
samples carrying either griseofulvin dispersions or dispersions of griseofulvin
loaded TOPSi nanoparticles. The UV/Vis measurements were carried out using
a Labrox (Finland) UV spectrophotometer and UV-star (Greiner, Germany)
microplates. The sample optical thickness was 5.7 mm. The transmitted
intensity at the wavelength of the principal characteristic absorbance peak of
griseofulvin in the UV/Vis spectrum (λ = 292 nm) was observed in the
measured samples [375]. Subsequently, the Cgr in the measured solutions were
calculated according to the Beer-Lambert law. Calibration curves were obtained
by measuring corresponding solutions with known values of Cgr in the range of
0–4 µg/ml. The measured values were compensated for replenishment of the
dissolution medium for each withdrawn aliquot in the dissolution experiment
(Chapter 3.2.15).
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3.2.15. In Vitro Drug Dissolution Modelling
In paper III, the dissolution rate of griseofulvin from the free griseofulvin
powder, and produced micromatrix particles was investigated. Both HCl
(pH 1.2) and PBS (pH 6.8) were used as dissolution media to simulate gastric
and small intestine pH conditions, respectively. Each dissolution experiment
was completely carried out in triplicate, at a constant temperature of
T = 37 ± 2°C in a magnetically stirred (100 rpm, tightly-fitted stirring bars)
25.0 ml volume of the dissolution medium. To satisfy the sink conditions, the
initial griseofulvin mass mgr of each dissolution sample was kept constant at
25 ± 1 µg, corresponding to Cgr = 1.0 µg/ml for a sample completely dissolved in
the stirred medium. Aliquots of 500 µl were withdrawn from the dissolution
medium at pre-determined time points, and replaced with fresh dissolution
medium. The aliquots were centrifuged using a MicroCL 17 centrifuge
(Thermo, Germany). From the supernatant, two 200 µl samples were obtained
for Cgr measurements (Chapter 3.2.14).
3.2.16. In Vitro Drug Permeation Modelling
In paper III, intestinal drug permeation was modelled in vitro in Hank’s
balanced salt solution (HBSS, pH 7.4), using cell co-culture monolayers that
consisted of the large intestine carcinoma line Caco-2 [281], and a HT29
adenocarcinoma line (ratio 90:10). Transwell cell culture inserts (Corning Inc.,
U.S.A.) were used. The experiments were carried out in triplicate, at T = 37°C.
Aliquots of 200 µl were withdrawn from the basolateral compartment at pre-
determined time points, and centrifuged. Cgr was measured from the
supernatant by HPLC (Chapter 3.2.11). The withdrawn aliquots were replaced
with fresh buffer to retain a constant volume. The integrity of the cellular
barriers was quantitatively and non-destructively determined in before and
after the experiments by monitoring the transepithelial electrical resistance
(TEER) [389]. A Millicell-Electrical Resistance System (Millipore, U.S.A.) was
used for TEER monitoring.
3.2.17. Taguchi Experiment Design
In paper IV, a two-level L12 orthogonal array (OA) was used to design the
fractional factorial experiment (FFE) [390]. Ten control factors and a dummy
factor were assigned to investigate the optimization of the bi-polar
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electroencapsulation process. Microcapsule samples were prepared in triplicate
(n = 3) in three random-order full cycles of the 12 trial conditions, and
subsequently the confirmation experiment. The significance of the factor effects
on the measured microcapsule properties and electroencapsulation process
yield were analyzed and classified by analysis of variation (ANOVA), and
complementary data analysis methods.
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subsequently the confirmation experiment. The significance of the factor effects
on the measured microcapsule properties and electroencapsulation process
yield were analyzed and classified by analysis of variation (ANOVA), and
complementary data analysis methods.
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4. Results and Discussion on Papers
The most important results of papers I–IV are summarized and discussed
briefly in Chapters 4.1–4. The complete experimental arrangements, results,
and detailed discussions are presented in the original publications, which can
be found reprinted at the end of this book.
4.1. Paper I
A bi-polar parallel nozzle electroencapsulation system of an adjustable
geometry was designed and built for the experimental work in paper I. The
electroencapsulation process using the setup was described in detail. With the
relevant electrospraying liquids as starting materials, the single-step
electroencapsulation process was used for production of two types of PSi
carrier particles: microcapsules of a liquid glycerol core and a solid Eudragit
E 100 shell composition, with TOPSi micro- or nanoparticle dispersions as
payloads in the core liquid; as well as solid Eudragit L 100 micromatrix particles
with embedded payloads of griseofulvin loaded TOPSi nanoparticle
dispersions. The integrity and structure of the produced microcapsules and
micromatrix particles were characterized by imaging methods. Limitations and
efficiency of the used electroencapsulation setup were discussed, and future
improvements were proposed.
For the microcapsule production, extreme values of polymer concentration
Cpol were used in paper I in order to refine the limits fit for the continuous
production of intact and durable microcapsules. It was experimentally verified
that various conductivities Κ could be attained for glycerol in the stable CJM
electrospraying region by NaI doping or heating, and a value of Κ close to the
observed maximum was used for the core liquid. For the selected liquids
electrosprayed in CJM, the most important parameters for tuning the
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encapsulation and collection efficiencies in situ were found to be the liquid flow
rates Qi, which affect the core and shell liquid droplet size and charge
distributions. Consequently, varying the Qi also affects the structure, size, and
charge distribution of microcapsules.
Spherical, intact and mechanically durable capsules were produced at the
higher Cpol = 250 mg/ml. On the contrary, at Cpol = 50 mg/ml, the capsules were
irregularly shaped, faulty and fragile. For both concentrations, the average
capsule size was 30 µm. Furthermore, the shell layer was observed by µCT
imaging to be on average 3 µm thick for both concentrations. According to the
result, the shell layer delicacy when using the lower Cpol was likely to be at least
partially caused by a lower shell layer density (higher porosity). It was
concluded that in the experimented Cpol range, mechanically handleable and
dosable microcapsules, suitable for the protection of the PSi payload until its
release in the gastric conditions, can be produced. The minimum usable Cpol
was found to reside above 50 mg/ml. In the nanoCT images of Figure 8, the
distributions of the TOPSi nanoparticles inside the microcapsules can be
partially observed. According to the images, the largest of the
electroencapsulated TOPSi particles appear to remain dispersed.
Figure 8. A nanoCT 3D-reconstruction of a pair of core-shell microcapsules produced
by bi-polar parallel nozzle electroencapsulation, as viewed from five different angles in
45° increments. The microcapsules consisted of a glycerol core with dispersed TOPSi
nanoparticles (CTOPSi = 10.1 mg/ml), inside a solid Eudragit E 100 polymer shell. In the
images, the largest of the dispersed TOPSi nanoparticles can be observed clearly as light
areas inside the microcapsules. Outside the capsules, some imaging artifacts (strong
lines and a bubble) are present. The imaging pixel resolution was 65 nm.
For micromatrix particles, reduction of Cpol from the highest continuously
electrosprayable concentration was observed to result only in a decreased
micromatrix particle size, and no clear minimum usable value for Cpol was
found. Therefore, a value close to the maximum Cpol was used exclusively.
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According to microscope imaging, the drug loaded TOPSi nanoparticles were
evenly dispersed in the produced solid and durable micromatrix particles. The
particles were of an irregular, wrinkled shape, and of some tens of µm in size –
ideal for the mechanical handling of the embedded TOPSi nanoparticles as a
dry micropowder, and for fast TOPSi release in the small intestine pH
conditions, where the matrix material dissolves.
Typical electroencapsulation efficiencies in paper I were observed to be 5–
10% for microcapsules, and 10–20% for micromatrix particles. This difference
was probably in large part due to the symmetrical nature of the micromatrix
particle production, resulting in a natural atomization current balance, and
thus efficient neutralization of the colliding droplets. The two types of carriers
complemented each other in the usable range of materials, such as the solvents,
polymers and PSi surface chemistries. Consequently, PSi particle payload
release triggered in either gastric or small intestine pH conditions was
concluded to be achievable, depending on the carrier type.
4.2. Paper II
In paper II, a novel polymorphic form of piroxicam was discovered by
electrospraying a chloroform solution of piroxicam. The electrosprayed form
was characterized extensively, and compared to the corresponding literature
data obtained for the previously known piroxicam polymorphs (forms I–III),
the unconfirmed α1-form, and piroxicam monohydrate (Chapter 3.1.1).
XRD analysis was the most important single method in the distinction of the
electrosprayed crystal structure from the previously known polymorphs of
piroxicam. A unique diffractogram was measured for the electrosprayed
piroxicam, which did not match the diffraction patterns of any of the known
piroxicam polymorphic forms or the crystal structures of any other compounds
found in the available databases. The electrospraying parameters U, Q, and p
did not affect the electrosprayed crystal structure. For reduced p, the
amorphicity of the sample increased, as previously observed for other drug
materials [113]. Furthermore, in a VTXRD analysis the electrosprayed
piroxicam was observed to recrystallize completely into form I when heated
(Figure 9). Anisotropic thermal expansion of the electrosprayed crystal
structure was observed, indicating that the piroxicam molecules were possibly
packed in parallel in the electrosprayed crystal lattice, similarly to the packing
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in the known piroxicam crystal lattices [381,382,384,386,391]. In storage at
ambient conditions, the amorphous phase of the electrosprayed piroxicam
sample was concluded to crystallize into forms I and III during the first 43 days.
After 127 days, no further significant changes in the sample had occurred, and
the electrosprayed crystal structure did not exhibit signs of deterioration. The
result was concluded to indicate stability of the electrosprayed crystal structure
at ambient conditions.
Figure 9. Recrystallization of the electrosprayed piroxicam (peaks denoted E1–E28)
into form I (indexed peaks) under heating, as measured by VTXRD.
According to DSC measurements, the first endotherm onset temperature
was 179.2 ± 2.3°C for the electrosprayed piroxicam samples. The result does not
match reported values of any of the previously known piroxicam polymorphic
forms.  The onset temperature of recrystallization to form I was measured as
185.5 ± 0.8°C. These temperature results agree well with the diminishment of
the electrosprayed form diffraction peaks as well as the emergence of form I
diffraction peaks, both processes observed to initiate for the most part at 175.0–
182.5°C, as seen in Figure 9. No impurities or degradation products were
observed, as confirmed by the HPLC analysis. Raman and FTIR spectra of the
electrosprayed form also differed from form I and the amorphous form of
piroxicam.
In a previous study, crystallization of piroxicam from a large volume of
chloroform solution yielded either form I or form II [392]. However, solvent
evaporation from the electrosprayed chloroform droplets, partially taking place
in a strong electric field, seem to provide unique circumstances for piroxicam
crystallization. A novel polymorphic form of piroxicam was concluded to form
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under these conditions. As soon as the results can be confirmed by another
group, the obtained new polymorphic form of piroxicam was suggested to be
referred to as form IV.
The novel polymorphic form of piroxicam characterized in paper II has
already received recognition, but its classification has created some confusion
[15,393,394], as another suspected piroxicam polymorphic form has been
previously regarded as form IV [395]. However, the characterization of the
previously named crystal structure has been limited to only DSC measurement,
where a weak melting peak with the onset at 164.1°C was observed [395]. A few
months after the publishing of paper II, the discovery of yet another new
polymorphic form of piroxicam, designated as form V, has been reported [396].
4.3. Paper III
Two types of gastric-resistant micromatrix particles carrying griseofulvin
(Chapter 3.1.1) as a model drug were produced by electroencapsulation, to
obtain a controlled release and enhanced dissolution of the drug at small
intestine pH conditions, after the particles pass through stomach conditions
without exposing the drug material to intestinal metabolism. GE type particles
consisted of a disordered griseofulvin solid dispersion in an Eudragit L 100
polymer micromatrix. For GPE type particles, griseofulvin-loaded TOPSi
nanoparticles were dispersed to the Eudragit L 100 matrix.
In XRD measurements of fresh GE and GPE particles, as well as samples
stored at accelerated conditions (RH 67%, T = 30°C) for 6 months, the
griseofulvin solid state was observed to be disordered, or “X-ray amorphous”:
no diffraction peaks were observed. To elaborate, the griseofulvin was dispersed
in the polymer matrix in a molecular form, in amorphous clusters, or in a
nanocrystalline form, with a crystal size t too small to produce distinguishable
diffraction peaks. Using the Scherrer formula and corresponding physical
mixtures of crystalline griseofulvin and Eudragit L 100 as reference samples, it
was estimated conservatively that if griseofulvin was in nanocrystalline form in
the micromatrix particle samples, t could not have been larger than 8 nm [282].
No griseofulvin crystallinity was observed in any of the samples in DSC
measurements, either. It has been shown in previous studies that the drug
remains in an amorphous form when loaded to the pores of TOPSi
nanoparticles [16,276]. It was concluded that the solid state of griseofulvin in
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the samples was highly disordered, and stable. For comparison, the spray-
drying method only yielded crystalline griseofulvin microparticles in a previous
study [315].
Both of the solid dispersion formulations quickly released the griseofulvin
payloads in vitro at pH 6.8, and were found to drastically improve the
griseofulvin dissolution rate, as compared to free, crystalline griseofulvin
powder. At pH 1.2, very little griseofulvin leakage was detected from the GE
and GPE particles during a period of 120 minutes, whereas the dissolution rate
of free griseofulvin remained practically independent of the pH. In Figure 10, a
combined dissolution graph with a simulated transition from the stomach to
the duodenum is shown for free griseofulvin, as well as the GE and GPE
particles. No significant differences were observed in the dissolution behavior
of GE and GPE particles.
Figure 10. Left: The measured griseofulvin in vitro dissolution profiles for free
griseofulvin (white rectangles), GE particles (blue triangles), and GPE particles (ref
circles), shown with the simulated transition from the stomach to the duodenum pH
conditions. Top right: A microscope image of the produced GPE particles. Bottom
right: A microscope image of free, crystalline griseofulvin.
Griseofulvin permeation was measured for free griseofulvin as well as the
GE and GPE particles in vitro across Caco-2/HT29 co-culture cell monolayers,
which mimic the human intestinal in vivo conditions closely [397]. Significantly
different results were obtained for each sample type. The permeation from both
of the electroencapsulated particle types was multifold as compared to the free
griseofulvin, as expected due to the easily dissoluble form of griseofulvin in the
polymer matrices. Perhaps surprisingly, the performance of GPE particles was
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far superior to the other sample types, and as high as a ten-fold improvement in
the permeation burst during the initial 30 minutes as compared to free
griseofulvin was observed. It has been hypothesized that the induced local drug
supersaturation in the vicinity of the drug releasing PSi nanoparticles could
lead to enhanced drug permeation, when the PSi nanoparticles attach to the
mucus layer on the intestine wall. However, this phenomenon is not well
understood as of yet [18,352,354,366].
4.4. Paper IV
The influence of ten electrospraying parameters on the properties and yield of
core-shell microcapsules produced by electroencapsulation was investigated in
a FFE utilizing a two-level L12 OA (cf. Chapter 3.2.17). The capsules consisted
of a glycerol core with optionally dispersed PSi nanoparticles, and an Eudragit
E 100 polymer shell: a composition first introduced in paper I. Based on
preliminary experiments, suitable electrospraying parameter values were
chosen to ensure a good coverage of the functional electroencapsulation
regime, and assigned as factor levels.
To summarize the FFE results, the most significant factors in their chosen
ranges for the measured microcapsule structure, yield, and collection efficiency
related quantities were found to be T, CNaI, Qc, and Qs. The experiment showed
that Cpol could be varied within the chosen range to independently adjust the
capsule shell thickness to a significant degree. The chosen levels of factors |Us|
and |Uc| did not exhibit significant effects on the electroencapsulation process,
except a possible minor influence of |Us| on the average and variation of the
capsule core-shell mass ratio. Finally, the applied ranges of Ctalc, and CPSi, as well
as the nozzle polarity were found to be insignificant for the measured
electroencapsulation process quantities in the FFE. However, the presence of a
PSi nanoparticle payload (CPSi > 0.0 mg/ml) increased the CJM threshold
atomization voltage for the core liquid, which was accounted for by setting the
|Uc| factor levels relative to the CJM threshold voltage. Thus, the PSi
nanoparticle payload in the used concentrations was not observed to affect the
electroencapsulation process significantly, as long as |Uc| was adjusted
according to the payload.
T and CNaI were the most influential factors on the overall capsule yield and
collection efficiency, with the response and signal to noise ratio (S/N) charts of
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the latter quantity shown in Figure 11 as an example. At T = 23°C and
CNaI = 0.50 mg/ml (factor levels 1), the electrospraying process was clearly more
efficient and consistent, as compared to T = 37°C and CNaI = 1.00 mg/ml (factor
levels 2). Notably, at the lower T and CNaI levels, a slightly larger capsule core
diameter was observed as well. These effects were for the most part due to the
difference in core liquid conductivity Κc between the factor levels for both T
and CNaI. The lower Κc at factor levels T = 23°C and CNaI = 0.50 mg/ml resulted
in a comparatively large electrosprayed core droplet size (Equations 11, 14,
and 17), and thus a decrease in the attainable core droplet charge to mass ratio
(Equation 5). Between the chosen factor levels, T was slightly more influential
on Κc than CNaI. Moreover, T influenced the electroencapsulation process in
other manners as well, as it also significantly affected core liquid viscosity ηc,
solvent evaporation rate, and possibly shell liquid conductivity Κs. On the other
hand, CNaI influenced Κc in a practically independent manner, and did not
significantly affect other core liquid parameters, such as ηc or ρc, in the chosen
factor range.
Figure 11. Based on various characterizations of the produced microcapsules, such as
size distribution measurements (top left) and composition measurement using TGA
(bottom left), response and S/N charts (right) were derived for quantities related to the
electroencapsulation process efficiency and microcapsule properties.
During the FFE trials, electroencapsulation efficiency was on average
14 ± 3%. This efficiency improvement from paper I was concluded to be in a
large part due to the larger chamber, and careful selection of the trial factor
level ranges. Using the optimal combination of factor levels as determined from
the FFE trial results, the response and consistency of capsule mass yield,
75
electroencapsulation efficiency, and core liquid (payload) mass proportion in
the capsules were all simultaneously optimized. As a result, an average
electroencapsulation efficiency of 48 ± 9% was observed in the FFE
confirmation experiments.
In additional experiments, microcapsule samples were produced for a varied
Qc. The core and shell liquid atomization currents Ic and Is, and electrosprayed
volume mean droplet sizes ����� and ����� were measured. The results showed a
good agreement of the Ic and ����� scaling laws relative to Qc (Equations 12
and 13). Consequently, the volume mean core droplet charge �� was observed
to scale as �� ∝ ���.��±�.��, whereas the exponent has been previously shown to
equal ½ [74]. It was concluded from the results that the optimal factor levels of
Qs, T, and CNaI minimized |Ic + Is| in the previous FFE experiment. As Qc was
adjusted to 0.60 ml/h from the optimal level of 0.50 mg/ml as determined in the
FFE, an increased electroencapsulation efficiency of ~56% was achieved.
Additional improvement in efficiency could possibly be gained to an extent by
further increasing Qc. For reference, the highest attainable electroencapsulation
efficiency for the used setup was estimated roughly as ~70%, due to limited
sample collection dish coverage of the electroencapsulation chamber bottom
area. The trend of an increasing core liquid proportion in the capsules was
clearly observed, as Qc was gradually increased. The measured data suggests it is
possible that the capsule composition did not change steadily, but in waves or
steps as Qc was varied. Unfortunately, the amount of data points and
measurements was inadequate to conclusively determine such details. A
possible explanation for an unsteady change of capsule composition as a
function of Qc could be provided by the nature of change in the average
number of core and shell droplets that compose a capsule (nc and ns): according
to the obtained data in the Qc sweep range, nc decreased from 6 to 2, while ns
increased from 2 to 3. In a single microcapsule, the number of droplets of each
species is always whole. Furthermore, the size and charge distributions of the
electrosprayed main droplets of both species were determined to be quite
narrow, so it is a possibility that the capsule composition change as a function
of Qc is not perfectly smooth, but instead changes in smoothed, discernible
steps for as long as the number of droplets composing a capsule is small. The
possible role of highly charged satellite droplets in the formation and
neutralization of capsules is important, but was not investigated in the present
work.
31004982_Turun_yliopisto_Vaitoskirja_Jorma_Roine_Luonn_tiet_ja_tekn_tdk_sisus_19_01_22.indd   90 22.1.2019   8.08.14
74
the latter quantity shown in Figure 11 as an example. At T = 23°C and
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(bottom left), response and S/N charts (right) were derived for quantities related to the
electroencapsulation process efficiency and microcapsule properties.
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It was concluded that to achieve an optimal efficiency of the bi-polar parallel
nozzle electroencapsulation process to produce core-shell microcapsules, a
feasible approach is to keep Κc relatively close to the lower end of the stable core
liquid CJM regime. After T has been set, coarse adjustments to Κc should be
made by changing CNaI. With Qs set to the highest continuously operational
level, Qc should be used for final adjustment of the atomization current balance.
The atomization voltages |Us| and |Uc| should be selected near the lower limit of
CJM, with a tolerance for fluctuations. In this work, the electroencapsulation
process was found to be equally efficient regardless of the presence of a PSi
nanoparticle payload dispersed in the core liquid.
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5. Conclusions
Using model polymers and pharmaceutical materials, bi-polar parallel nozzle
electroencapsulation was shown to be a feasible single-step method for the
production of drug carrier particles that potentially improve the oral
bioavailability of a carried poorly soluble drug by targeting the drug release,
and by enhancing the drug dissolution properties. Two types of carrier particles
were produced: Eudragit L 100 polymer micromatrix particles carrying a
stabilized, disordered drug solid dispersion or a stabilized dispersion of drug
loaded PSi nanoparticles in the solid matrix; and glycerol core-Eudragit E 100
polymer shell microcapsules carrying a dispersed payload of functional drug
carrier PSi nanoparticles in the liquid core. The release of the shielded payload
was targeted at predetermined (small intestinal or gastric) pH-conditions. The
produced enteric micromatrix particles were shown in vitro to be gastro-
resistant, and to greatly enhance drug dissolution and permeation at the small
intestine conditions.
Moreover, it was shown that electrospraying holds great potential as a
unique method for the discovery and production of new stable polymorphic
forms of pharmaceutical materials. Consequently, the oral bioavailability of
certain drug materials could possibly be improved without the need for more
complicated formulations to stabilize the amorphous or molecular form.
The bi-polar parallel nozzle electroencapsulation process featured in this
work for core-shell microcapsule production is intriguing in its complexity.
With a pair of electrosprays producing two species of mutually immiscible and
oppositely charged droplets of generally different size and absolute charge
distributions into a common encapsulation chamber to form microcapsules at
various conditions, numerous variables could potentially affect a certain
property of the capsules, or another particular aspect of process. Therefore,
empirical studies are invaluable in attempts to understand and control the core-
shell microcapsule production process. In comparison, the micromatrix
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particle production process was simpler: as identical electrosprays could be
used, the process was in part equivalent to an electrospraying process of a
double yield. In this work, the necessity of external droplet neutralization was
eliminated in exchange for a larger mean particle size by the use of opposite
electrospray polarities.
In core-shell microcapsule production, the capsule yield and properties
could be controlled quite extensively by adjusting the electroencapsulation
parameters, such as the electrospraying liquid compositions and flow rates, as
well as the electroencapsulation geometry and conditions. The most significant
electroencapsulation parameters were identified and optimized for efficient
core liquid utilization and yield. As a result, nearly ideal electroencapsulation
efficiency and a high core liquid mass ratio was achieved for the capsules, while
retaining a sufficient shell thickness for good durability. Importantly, the
presence of a PSi nanoparticle payload in the core liquid did not disrupt the
electroencapsulation process, as long as the atomization voltage was adjusted
accordingly.
Compared to alternative electroencapsulation geometries, such as the co-
axial nozzle electroencapsulation technique, the bi-polar parallel nozzle
electroencapsulation is arguably a more complicated process. As an advantage
of the parallel nozzle technique, additional neutralization may not be necessary
in the production of core-shell microcapsules or micromatrix particles. In
addition, the bi-polar parallel nozzle electrospraying technique can be applied
for micromixing, the production of microreactors, or building of Janus
particles. In the field of pharmacy, the technique could also be used for the
production of spherical dual-drug nanoparticles, or for the production of
complex micromatrix particles consisting of compounds that together in a
single solution could not be electrosprayed due to constituent interactions.
In future research efforts on bi-polar parallel nozzle electroencapsulation,
the further mapping of suitable electroencapsulation material combinations is
necessary. Perhaps more importantly, the focus should be on the successful
implementation of scale-up techniques in order to drastically improve the
overall microcapsule or micromatrix particle yield, which in the present work
remains unsuitably low for most practical drug delivery applications. The most
promising scale-up approaches include various electrospraying nozzle array
arrangements, as well as the use of line or surface electrospraying sources
instead of point sources.
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